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Purpose:  To establish benchmarks for assessing workload, staffing, and productivity in 
state psychiatric hospital pharmacy departments, and to compare productivity by bed 
size.   
 
Methods:  An electronic survey of state psychiatric hospitals was conducted.  Hospitals 
were categorized based on number of occupied beds.  Descriptive statistics using 
Student’s t-tests, Pearson Chi-Square, and Pearson Correlations were used to characterize 
the data and compare productivity by bed size. 
 
Results: Responses were received from 41 hospitals (35.7%) and benchmarks were 
established.  Respondent hospitals did not differ from non-respondents based on 
demographic data from the American Hospital Association (AHA) DataViewer. There 
was a positive correlation between daily census, patient days, expenditures, paid hours 
and productive hours per week, workload metrics, total pharmacy staff, and occupied bed 
size (r=0.381-0.991, p<0.05).  Over 30% of hospitals reported using no indicators to 
monitor pharmacy productivity. Productivity ratios differed between Very Small/Small 
and Medium/Large hospital groups:  mean pharmaceutical expenditures per 100 occupied 
beds and per 1000 patient days (p=0.017 and 0.05 respectively), mean FTEs per 1000 
doses dispensed/administered per month and per 100 occupied beds (p=0.042 and 0.026), 
and mean pharmacist and technician FTEs per 100 occupied beds  (p=0.012 and 0.019 
respectively).  
 
Conclusion:  Results of the survey suggest staffing, workload, and productivity metrics 
to be dependent on bed size, with larger hospitals operating more efficiently than 
hospitals of lower bed size. Over 30% of hospitals reported using no indicators to 
monitor pharmacy productivity. 
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Chapter One:  INTRODUCTION 
The purpose of the proposed study is to develop benchmark statistics for use in 
assessing workload, staffing, and productivity in hospital pharmacy departments of state 
psychiatric hospitals.  Such comparative statistics are necessary to allow pharmacy 
administrators a means to benchmark efficiency metrics to those of other state psychiatric 
hospitals of similar size and to provide data to enable policy makers to better assess 
staffing and resource needs in state owned psychiatric hospitals. 
Background and Need 
 Healthcare in the United States has changed significantly in the past 20 years.  
There is an ever-increasing pressure to improve the healthcare system by:  (1) improving 
the experience of care, (2) improving the health of populations, and (3) reducing per 
capita costs of healthcare (Berwick, Nolan, & Whittington, 2008).  Healthcare 
organizations, including state psychiatric hospitals, seek to increase efficiency by 
decreasing costs and eliminating waste, while at the same time increasing the quality and 
outcomes of care provided.   
The Benchmarking Process 
Per Witt (2002), benchmarking “creates the context in which to identify issues, set 
targets, and take action to improve performance” (Witt, Practice re-engineering through 
the use of benchmarks: Part 1, 2002, p. 191).  The use of operational benchmarking is 
increasing within health systems as a tool for continuously measuring and improving 
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 individual departmental performance.  External benchmarking can be helpful to find and 
implement best practices of peer organizations (Rough, McDaniel, & Rinehart, 2010).   
To cultivate success, health systems, including pharmacy departments, must measure 
performance of their operations against benchmarks and then apply that knowledge to 
performance improvement.  Benchmarking provides a continuous process for measuring 
and learning about productivity, costs, and quality.  Benchmarks should be used to create 
accountability and drive performance to achieve the “best practices” standard (Witt, 
Practice re-engineering through the use of benchmarks: Part 1, 2002, p. 187). 
Internal benchmarking is most commonly found in practice (i.e., comparison of 
this years budget to last year); however, this is least helpful for re-engineering processes 
or improving performance.  Internal benchmarks are weak in their capacity to identify the 
critical drivers that lead to performance improvement.  To clarify factors that drive 
performance, it is important to use external benchmarks (Witt, Practice re-engineering 
through the use of benchmarks: Part 1, 2002, p. 188). 
Industry benchmarking is a form of external benchmarking, which includes 
benchmarking against organizations in the same business, which is not competing for 
customers.  The advantages of this type of external benchmarking is that organizations in 
the same business (i.e. psychiatric hospitals) are faced with similar issues and or 
practices, with a similar willingness to share data, with potential to lead to best 
performance targets (Witt, Practice re-engineering through the use of benchmarks: Part 1, 
2002, p. 188).   
A particular challenge with industry benchmarking is that there may be unknown 
differences in the organizations, which should be considered (Witt, Practice re-
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engineering through the use of benchmarks: Part 1, 2002, p. 188).  When choosing an 
organization to benchmark against, it is important to compare against an organization that 
is as similar as possible to avoid benchmarks that may not be relevant; however, it should 
be noted that differences in organizational characteristics do not necessarily invalidate a 
benchmark.  Performance targets should be established using both internal history and 
external benchmarks for guidance.  Benchmarks are not absolute and should only serve to 
provide direction to identify potential problems and solutions (Witt, Practice re-
engineering through the use of benchmarks: Part 1, 2002, pp. 189-190). 
Benchmarking in Pharmacy 
Hospital administrators expect pharmacy directors to be able to monitor and 
articulate performance-related metrics, by constructively identifying shortcomings and 
opportunities for improvement (Rough, McDaniel, & Rinehart, 2010).  Effective 
benchmarking allows pharmacy administrators to identify opportunities to improve 
workflow efficiency, patient care services, and financial performance.  Without 
appropriate benchmarks, staffing and resource allocations may be made that negatively 
affect the safety and quality of the medication-use process (Rough, McDaniel, & 
Rinehart, 2010).  
The inability to effectively and efficiently measure workload and productivity in 
hospital pharmacy has been a long-standing issue for the profession, dating back to the 
1960s (Gupta, et al., 2006; Bartscht, Estrella, & Rothenbuhler, 1965).  Hospital pharmacy 
services are numerous and measurement is difficult (Gupta, et al., 2006). National 
standardized methods for measuring pharmacy productivity have not yet been defined in 
the United States, nor have standardized optimal staffing and productivity metrics 
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(Gupta, et al., 2006; 2007; Glazier & Malen, 2007).  There continues to be growing 
concern within pharmacy about how best to evaluate staffing and resource allocation 
needs without adequate methods to measure workload and productivity (Gupta, et al., 
2007).  
There is a lack of widely adopted productivity measurement methods for the 
profession of pharmacy.  Measuring pharmacy department workload and outcomes of 
non-distributive functions are known challenges; however, most hospital pharmacies 
collect some form of internal data for longitudinal benchmarking.  Access to data for 
external benchmarking is extremely limited (Rough, McDaniel, & Rinehart, 2010).  
Similar data from psychiatric hospital pharmacies is even more limited. 
The American Society of Health System Pharmacists  (ASHP) conducts a national 
survey to define pharmaceutical services in acute care hospitals, and publishes pharmacy 
metrics on prescribing, transcribing, dispensing, administration, monitoring, and patient 
education.  These reports include data on pharmacist and pharmacy technician staffing 
levels, categorized by the number of staffed beds, with the most recent data being 
reported in 2016 (Pedersen, Schneider, & Scheckelhoff, 2013;  2014; 2015; 2016).  This 
data is valuable to hospital pharmacy administrators; however, the data are specific to 
acute care hospitals.  Psychiatric hospitals were excluded from the survey.   
State psychiatric pharmacy departments primarily focus on the psychiatric needs 
of the patients they serve.  Psychiatric hospitals often include a medical service; however, 
most complicated medical needs are referred to an acute care hospital for management.  
Psychiatric hospitals do not generally include surgical services, labor and delivery 
services, or typical medical emergency services, which would be found in an acute care 
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hospital.  Most medications dispensed in psychiatric hospitals are in oral formulations, 
with more limited amounts of intravenous medications compared to an acute care 
hospital.  In general, pharmacy services provided are of a different nature than those 
provided in an acute care hospital making the acute care hospital pharmacy department a 
less than optimal comparison group for external benchmarking.  
No current external metrics and benchmarks for pharmacy staffing, workload, and 
productivity for psychiatric hospitals have been published.  The last study published that 
involved psychiatric hospitals was based on data collected in 1989.  Both pharmacy 
practice and hospital care has changed greatly in the 27 years since that study (McKee, 
1991).   
Including the 195 state-operated psychiatric hospitals in the United States, the 
public mental health service delivery system serves 7.3 million people each year, under a 
$41 billion budget (National Association of State Mental Health Program Directors, 
2016; Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016, p. 7).  State resources for 
mental healthcare services are limited, requiring state hospitals to operate as efficiently as 
possible.  In order to direct scarce resources to areas of need, data is needed on costs, 
quality, and outcomes to completely assess the mental health system performance.   
Estimating that each of 195 psychiatric hospitals in the United States employs at 
least five pharmacists, an improvement in productivity by ten percent for example, would 
estimate an annual savings of approximately $9,750,000 in pharmacist salaries alone or 
the potential to redirect pharmacists to provide clinical services not currently provided.  
Based on published research, for every dollar invested in clinical pharmacy services at 
least four dollars in benefit can be estimated (Schumock, Butler, Meek, Vermeulen, 
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Arondekar, & Bauman, 2003, pp. 117,120), which in this case would extrapolate to 
$39,000,000 in savings to the public mental health system overall.  Considering the entire 
pharmacy department’s staffing level of approximately 10 full time equivalents (FTEs) 
per hospital, a ten percent improvement in overall productivity could approximate a 
reduction in 195 FTEs nationally.  Alternatively, hospitals that are under staffed may 
realize an opportunity to grow their departments to provide more pharmaceutical services 
and increase the quality of care provided to patients. 
The Treatment Advocacy Center (2016) recommends improved data collection to 
inform public policy (Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016).  This study 
will contribute to the body of knowledge about best practices being used to measure 
workload, staffing, and productivity metrics in state psychiatric hospital pharmacies, 
providing an additional tool to enable policy makers to better assess resource needs in 
state psychiatric hospitals. 
Problem Statement 
Current published benchmarks comparing hospital pharmacy staffing and 
workload ratios are limited to acute care facilities.  Psychiatric and behavioral health 
hospitals were excluded from recent published studies (Gupta, 2006; Pedersen, 2015).  
Thus, current external metrics and benchmarks for pharmacy staffing, workload, and 
productivity for psychiatric hospitals are not available.  Nevertheless, there is a need for 
this kind of data to measure and improve workload, staffing, and productivity in state 
psychiatric hospital pharmacies, and to enable policy makers to better access resource 




Research Objective and Research Hypothesis 
The objective of this study will be to obtain data from state psychiatric hospital 
pharmacy departments with the goal of developing current benchmark statistics for use in 
assessing workload, staffing, and productivity in similar pharmacy departments. Survey 
methodology will be utilized to conduct this study.   
Pharmacy directors will be asked to submit data on how productivity is measured 
in their department, including the metric used and frequency of measurement.  They will 
also be asked what managerial or clinical indicators are used to assess the effectiveness 
and quality of pharmacy work, such as pharmaceutical expenditures, number of adverse 
drug reactions, number of patient days per year, types of patients served (percent forensic 
versus non-forensic), turn-around time, etc.  Data will be collected on staffing levels, 
including the number of full time employees (FTEs) in each job class within the 
pharmacy and time spent doing different activities.  Data will be requested on various 
pharmacy statistics such as quantities of medications dispensed, total pharmacy 
expenditures, hours of operation, and types of non-distributive services provided by the 
pharmacy department. 
It is hypothesized that hospital volume statistics, pharmacy expenditures, hours of 
operation, FTEs, and dispensing workload will vary based on the size of the facility.  
Staffing levels per bed will likely be highest for small hospitals. Small hospitals must 
staff to a minimum level of service and safety.  It is hypothesized that workload 
(dispensing, hours of operation, and clinical services) will be highest for large hospitals. 
Large hospitals will be found to benefit from economies of scale and to operate more 




This study will be focused on pharmacy departments within government-owned 
psychiatric hospitals.  Pharmacy directors from member psychiatric hospitals of the 
Minnesota Multistate Contracting Alliance for Pharmacy (MMCAP) will serve as the 
sampling frame.  MMCAP is a group pharmaceutical purchasing organization (GPO) for 
government-owned entities across the United States; therefore, all hospitals studied will 
be from government-owned hospitals.   
There are 195 state operated psychiatric hospitals in the United States (Fuller, 
Sinclair, Geller, Quanbeck, & Snook, 2016, p. 7).  Of the 195, at least 156 are registered 
as hospitals with the American Hospital Association (American Hospital Association, 
2016).   Of the 156, 115 hospitals are current members of the MMCAP GPO and will be 






































Chapter Two:  REVIEW OF THE LITERATURE 
The purpose of the proposed quality improvement study is to develop benchmark 
statistics for use in assessing workload, staffing, and productivity metrics used in hospital 
pharmacy departments of state psychiatric hospitals.  Such comparative statistics are 
necessary to allow pharmacy administrators a means to benchmark efficiency metrics to 
those of other state psychiatric hospitals of similar size and to provide data to enable 
policy makers to better assess staffing and resource needs in state owned psychiatric 
hospitals. 
 The specific objective of this chapter is to provide a narrative review, employing a 
broad perspective of current issues, related to measurement, benchmarking, and 
improvement of workload, staffing, and productivity as applicable to psychiatric hospital 
pharmacies.  The specific search strategy is described, including the databases used, 
defined time period searched, search terms utilized, inclusion and exclusion criteria, and 
methods for abstracting information from selected articles. 
Methods Used to Conduct Literature Search 
 A searchable question was formulated to conduct an electronic literature database 
search as follows:  “For hospital pharmacy departments of government psychiatric 
hospitals in the United States, what are the current (within the past ten years) benchmark 
statistics for assessing workload, staffing, and productivity metrics?” 
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A keyword search was conducted through PubMed and CINAHL.  Data was filtered 
to include references from the past ten years, in humans.  All article types were included.  
The search was submitted through PubMed in the following order, including the resultant 
number of references found: 
1. Pharmaceutical services or pharmacy and hospital, limited to last 10 years 
and humans – 37,528 
2. Pharmaceutical services or pharmacy and hospital and productivity, limited to 
last 10 years and humans – 744 
3. Pharmaceutical services or pharmacy and hospital and productivity and 
workload, limited to last 10 years and humans – 29 
4. Pharmaceutical services or pharmacy and hospital and staffing, limited to last 
10 years and humans – 130 
5. Pharmaceutical services or pharmacy and hospital and staffing and manpower, 
limited to last 10 years and humans – 31 
6. Pharmaceutical services or pharmacy and hospital and psychiatric, limited to 
last 10 years and humans – 1716 
7. Pharmaceutical services or pharmacy and hospital and psychiatric and staffing 
and workload, limited to last 10 years and humans – 0 
8. Pharmaceutical services or pharmacy and hospital and psychiatric and staffing, 
limited to last 10 years and humans – 23,372 
9. Pharmaceutical services or pharmacy and hospital and psychiatric and 
workload, limited to last 10 years and humans – 23,371 
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10. Pharmaceutical services or pharmacy and hospital and benchmarking and 
staffing and workload, limited to last 10 years and humans – 2 
11. Pharmaceutical services or pharmacy and hospital and staffing and cost, limited 
to last 10 years and humans – 29 
12. Pharmaceutical services or pharmacy and hospital and staffing and survey, 
limited to last 10 years and humans – 48 
The keyword search matched well to MeSH terms including: “pharmaceutical 
services” or “pharmacy” or “pharmacies” and “hospitals” and “benchmarking” 
and staffing [all fields] and “workload.”  No new search terms were identified.   
When “psychiatric” was entered as a search term along with “staffing and 
workload,” the search yielded zero papers.  The lack of published articles in psychiatric 
hospitals regarding workload, staffing, and productivity represents a gap in the current 
body of evidence regarding this topic.   
References were included and excluded from review based on their applicability 
to the research question.  All papers identified as being applicable were logged into a 
spreadsheet and assigned a number.  As additional papers were found, they were added to 
the spreadsheet.  An electronic copy of each full-text paper was then obtained for review.  
Each paper was reviewed to determine if the content was applicable to the study question.  
Papers found to not be applicable after review, were marked to be excluded.  Many 
references were found to not be applicable, because they were specific to management of 
a particular disease state, specific care settings other than pharmacy, or pharmacy practice 
in countries other than the United States.  
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The searches numbered 3, 5, 10, 11, and 12 above were screened for applicable 
papers.  Of 139 papers, 18 duplicates were eliminated, and 94 were eliminated due to lack 
of relevance.  Twenty-seven papers were pulled and reviewed.  The reference sections 
were scanned for earlier articles that may have not been obtained through the ten-year 
search. 
A PubMed Clinical Queries search was completed using the criteria 
“Pharmaceutical services or pharmacy and hospital and staffing and cost.” The 
search yielded five papers under the clinical study category and 4 papers under the 
systematic review category.  One article was pulled for inclusion in the literature review, 
while one article was a duplicate from the primary search and the others were not 
relevant to the study question.  With the following criteria “Pharmaceutical services or 
pharmacy and hospital and psychiatric and staffing,” five papers of 23,995 were shown.  
Of these, none of the references were applicable.  Using the criteria “Pharmaceutical 
services or pharmacy and hospital and psychiatric and staffing and workload” yielded 
zero papers. 
A PubMed search was conducted on four key authors discovered in the literature 
review, including Shiraz R. Gupta, Glen T. Schumock, Steve S. Rough, and Craig S. 
Pedersen.  Of 106 articles published by these authors and obtained on literature review, 
18 articles were pulled for potential inclusion in the literature review.  Of those, nine 
were excluded (6 were duplicates and 3 were not relevant to the study question). 
A keyword search was conducted through CINAHL.  Data was not filtered.  All 
article types were included.  The search was submitted through CINAHL in the following 
order, including the resultant number of references found: 
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1. Pharmacy and hospital and psychiatric and staffing – 0 
2. Pharmacy and hospital and psychiatric and workload – 0 
3. Pharmacy and hospital and psychiatric and benchmark – 0 
4. Pharmacy and hospital and psychiatric and cost – 13 
5. Pharmacy and hospital and psychiatric and productivity – 0 
6. Pharmacy and hospital and psychiatric and manpower - 0 
The search numbered 4 above was screened for applicable papers.  Of 13 papers, 11 were 
eliminated due to lack of relevance.  Two papers were pulled and reviewed.   
In addition to the literature database searches, the author examined the reference 
sections of included articles to identify additional papers for consideration.  An additional 
78 papers were discovered. Ten papers were excluded after review, due to not being 
applicable to the study question. 
In total, 249 articles were initially screened for applicability based on how the 
content would help support or describe the basis for the research question.  See Figure 1. 
Of those, 25 were duplicates and 111 papers were excluded for lack of relevant subject 
matter.  The remaining 103 papers were categorized based on the following major 
themes:  history of the state psychiatric hospital, pharmacy services, operational 
benchmarking, and staffing, workload, and productivity metrics.  The following literature 









































































The State Psychiatric Hospital 
The public mental health service delivery system in the United States serves 7.3 
million people each year, under a $41 billion budget (National Association of State 
Mental Health Program Directors, 2016).  There are currently 195 state operated 
psychiatric hospitals in the United States (Fuller, Sinclair, Geller, Quanbeck, & Snook, 
2016, p.7).  State executives responsible for the public mental health delivery system are 
members of the National Association of State Mental Health Program Directors 
(NASMHPD).  These executives are Commissioners or Directors, generally appointed by 
the Governors in their respective states and are local members of the State Mental Health 
Authorities (SMHAs) (National Association of State Mental Health Program Directors, 
2014, p. 6).   
 State psychiatric hospitals assess, evaluate, and treat people with the most 
complex psychiatric illnesses who are at risk of harm to their self or others and who 
cannot be managed effectively in their communities (National Association of State 
Mental Health Program Directors, 2014).  They are essentially a safety net to provide 
care for those whose needs cannot be met elsewhere.   
To fully grasp the importance of the need for pharmacy departments to run as 
efficiently as possible, it is important to understand the history of the state psychiatric 
hospital and the challenges these facilities face to serve those whose needs are unable to 
be met in the community.  The public mental health system has been under increasing 
pressure to meet the mental health needs of American citizens.  The system has been 
subject to health care reform, economic restraint, and complex civil rights laws.  Most 
people with mental illness are served in the community; however, those with the most 
	 17	
	
complex mental health disease are served in state psychiatric hospitals (National 
Association of State Mental Health Program Directors, 2014).  The paragraphs below will 
describe the evolution of the state psychiatric hospital, including a description of their 
number, change in bed size over time, means for funding, and types of patients served. 
History of the State Psychiatric Hospital 
 It is important to understand the history of the state mental health system and how 
it has evolved, to fully appreciate the current role and financial position of the state 
psychiatric hospital.  The history of state psychiatric hospitals in the US is heavily 
interwoven by social policy and public attitudes toward “deviant” and dependent people 
(Hunter, 1999, p. 25). 
Before the 1820s, people who were considered to be deviant, criminal, or 
physically or mentally dependent were not confined to public institutions.  During 
colonial times, criminals were often immobilized in stocks and publically humiliated.  
They were charged with fines, whipped, and even hanged.  People suffering from 
extreme poverty or mental illness lived with their relatives or neighbors.  These people 
were not confined to state psychiatric hospitals (Hunter, 1999, p. 25). 
Beginning in the 1820s, public institutions of varying types were constructed, 
including penitentiaries, almshouses, reformatories, and insane asylums.  These facilities 
were built to manage the criminal, deviant, and dependent populations (Hunter, 1999, p. 
25).  When people were unable to be cared for by family or neighbors, “demented” 
people would be placed in local jails and charitable housing.  The local jail systems were 
eventually overused for this purpose (National Association of State Mental Health 
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Program Directors, 2014, p. 8).  The theory was that these facilities would promote stable 
societies and communities by restoring social balance (Hunter, 1999, p. 25).   
Early asylums were intended to provide moral treatment and guidance to people 
who were unable to live in or adjust to society.  The success of the asylums’ humanitarian 
approach coupled with reports of mal treatment in workhouses and almshouses 
eventually propelled the states to take responsibility for the treatment of people with 
psychiatric disabilities.  Advocacy of moral treatment reached its height in the UNITED 
STATES in the 1830s and 1840s (Hunter, 1999, p. 25).   
In the mid-1800s, a woman named of Dorothea Dix led a movement to establish a 
national policy for caring for people with mental illness.  Dix was a schoolteacher from 
Cambridge, Massachusetts.  Her work led to what became known as the 12,222,000 Acre 
Bill or the Indigent Insane Bill of 1854, which allowed for federal lands to be set aside 
across the country for the opening of asylums.  Her mission was to remove these people 
from the auspices of corporal punishment and rather emphasized the need for humane 
care based on compassion and moral treatment (National Association of State Mental 
Health Program Directors, 2014, p.8; Sharfstein, Whatever happened to community 
mental health?, 2000, p.617).  Dix’s movement argued that orderly routine, fostering 
social contact, exercise, and work could cure insanity more humanely and effectively 
than attempts to rid the body of demonic possession and extreme measures of corporal 
punishment (Sharfstein, Whatever happened to community mental health?, 2000, p. 617). 
 After six years of intense work by Dix (Sharfstein, Whatever happened to 
community mental health?, 2000, p. 617), the bill passed Congress in 1854; however, 
President Franklin Pierce vetoed the bill stating that the responsibility for the care of 
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people with mental illness was the responsibility of the states, rather than the federal 
government (National Association of State Mental Health Program Directors, 2014, p. 8).  
President Pierce stated the following in his veto message to Congress (Sharfstein, 
Whatever happened to community mental health?, 2000, p. 617): 
“If Congress has the power to make provisions for the indigent insane, the whole 
field of public beneficence is thrown open to the care and culture of the federal 
government.  I readily acknowledge the duty incumbent on us all to provide for 
those who, in the mysterious order of providence, are subject to want and to 
disease of body and mind, but I cannot find any authority in the Constitution that 
makes the federal government the greater almoner of public charity throughout 
the United States.” – President Pierce, 1854  
The states were then left to fund state psychiatric hospitals with state tax dollars (National 
Association of State Mental Health Program Directors, 2014, p. 8).  This responsibility to 
the states, as defined by President Pierce, continues to be in place today and has 
contributed to the decline of state hospital beds and the presence of psychiatric units in 
general hospitals (Sharfstein & Dickerson, Hospital psychiatry for the twenty-first 
century, 2009, p. 687).  Dix continued her work and ultimately established 32 psychiatric 
hospitals in 18 states (National Association of State Mental Health Program Directors, 
2014, p.8; Sharfstein, Whatever happened to community mental health?, 2000, p.617).  A 
drawing of one of the psychiatric hospitals, Dix Hill Asylum, is rendered below.  See 
Figure 2.  What eventually became known as Dorothea Dix Hospital, served people with 





Figure 2:   
Dix Hill Asylum in 1872 
Raleigh, North Carolina  
 
Through the second half of the 19th century, these state supported asylums grew in 
size, as they eventually became large public hospitals housing not only people with 
mental illness, but those who needed long term care support without mental illness 
(National Association of State Mental Health Program Directors, 2014, p. 8).  They 
changed from small therapeutic programs into large custodial public hospitals 
(Sharfstein, Whatever happened to community mental health?, 2000, p. 617).  The 
facilities changed their service models based on the needs of the time.  Some became 
military hospitals during the Civil War, a place to quarantine and treat those with 
tuberculosis, and/or hospitals for World War I and II veterans (National Association of 
State Mental Health Program Directors, 2014, p. 8). 
 With the growth in size and change in service model, the quality of care became 
compromised over time.  Those who were once thought to be curable were accepted as 
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incurable with lifelong lengths of stay (National Association of State Mental Health 
Program Directors, 2014, p.8; Sharfstein, Whatever happened to community mental 
health?, 2000, p.617). 
 By the mid-1950s, with over 500,000 people residing in the state psychiatric 
hospitals, the United States had reached its peak of public-asylum psychiatry (Sharfstein, 
Whatever happened to community mental health?, 2000, p. 617).  They had become the 
primary mental health system in the United States.  Most were operated as self-sustaining 
communities, with service recipients tending the farms and working in the laundry 
facilities (National Association of State Mental Health Program Directors, 2014, p. 9).  
Unfortunately, overcrowding and underfunding had become an issue in most every state.  
State and local governments were often unwilling to allocate necessary resources to 
provide the level of care needed in state facilities (Hunter, 1999, p. 27).   
 President Truman signed the National Mental Health Act in 1946, after World 
War II veterans, suffering “battle fatigue,” raised federal concerns for mental health 
policy.  The National Institute for Mental Health was created in 1949.  Soon after came 
the development of antipsychotic medications, which were then provided to state hospital 
service recipients (National Association of State Mental Health Program Directors, 2014, 
p. 9). 
 In 1956, President Eisenhower signed the Social Security Disability Insurance 
Program (SSDI).  In the following 20 years, Medicare, Medicaid, and the Supplemental 
Security Income Program (SSI) would be passed.  These programs provided health 
insurance and funding to support not only people with disabilities, but also people with 
severe mental illness.  There was one catch.  With the institution of Medicaid in 1965, 
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Congress made it very clear that the state and local psychiatric hospitals were not to be 
funded through Medicaid funding (National Association of State Mental Health Program 
Directors, 2014, p. 9).   
Congress created the federal Institution for Mental Disease (IMD) Exclusion 
Rule.  The rule, still in effect today, excludes payment for service recipients between the 
ages of 21 and 64 who are in state psychiatric hospitals and any other hospital, in which 
more than 50% of beds with for patients with a primary diagnosis of a mental disorder.  
An institution for mental disease is defined as a “hospital, nursing facility, or other 
institution of more than 16 beds, that is primarily engaged in providing diagnosis, 
treatment, or care of persons with mental diseases, including medical attention, nursing 
care, and related services.”  Because of this rule, state psychiatric hospitals continue to 
depend primarily on state funding, with no supplementation by the federal government 
(National Association of State Mental Health Program Directors, 2014, p. 9). 
Later in the mid-20th century, many state psychiatric facilities were found to have 
poor and abusive conditions for service recipients.  Eleanor Roosevelt, Pearl Buck, and 
others established the National Mental Health Foundation, which began the movement 
toward deinstitutionalization (National Association of State Mental Health Program 
Directors, 2014, p. 9).   
In the 1950s, neuroleptic medications were introduced, which provided the first 
effective treatment for psychotic disorders (Sharfstein & Dickerson, Hospital psychiatry 
for the twenty-first century, 2009, p. 685). Chlorpromazine (Thorazine®) became 
available, which enabled many to be managed in the community.   
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The overriding motivation for deinstitutionalization was the states’ ability to shift 
the financial burden of care for the mentally ill to federal sources (Sharfstein & 
Dickerson, Hospital psychiatry for the twenty-first century, 2009, p. 685).  The 
Community Mental Health Centers (CMHC) Act of 1963, championed by President John 
F. Kennedy, supported state and federal reforms, which led to the downsizing of the state 
psychiatric hospital in support of community based treatment of mental illness (National 
Association of State Mental Health Program Directors, 2014, p. 10). 
The CMHC Act provided federal funding, for the first time in almost 100 years, in 
the form of seed grants to support community-based services.  Over time, the funding 
decreased with the expectation that third party payers and alternative funds would replace 
the grant funding (National Association of State Mental Health Program Directors, 2014, 
p. 10). 
The United States faced budget constraints of the Vietnam War and other 
domestic programs.  In 1978, Congress passed legislation, which expanded the scope of 
the CMHCs to serve additional groups such as those with substance use disorders, 
children, and older adults.  This resulted in a shift towards programs that would meet the 
needs of more people, leaving less community resources for those with mental illness 
(National Association of State Mental Health Program Directors, 2014, p. 10). 
During Jimmy Carter’s presidency in 1980, mental health reform again gained 
political attention.  He created the first President’s Commission on Mental Health and the 
passage of the Mental Health Systems Act, which put a renewed emphasis on the 
CMHCs to support severe mental illness.  The Reagan presidency repealed the act in 
1981.  Congress eventually cut federal mental health funding and converted the CMHC 
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funding into block grants for the states.  The block grants would be used by each state as 
needed to fund community programs, based on their local needs (National Association of 
State Mental Health Program Directors, 2014, p. 10). 
In the late 1970s and 1980s, general hospitals began developing small inpatient 
psychiatric units, which would expand access for mental health patients without 
qualifying as an IMD.  Coverage was expanded for outpatient case management and day 
treatment services.  Due to the workaround from qualifying as an IMD, the use of general 
hospitals grew as an alternative to state psychiatric hospitals and most freestanding 
private psychiatric hospitals for acute psychiatric care.  This left the state psychiatric 
hospitals caring for the most severe patients, who require intermediate and long-term 
inpatient care.  Many states shifted care of older persons with serious mental illness into 
nursing homes were a larger amount of federal funding could be pulled down for people 
over the age of 65 (National Association of State Mental Health Program Directors, 2014, 
p. 10). 
In 1971, the Intermediate Care Facilities for Mental Retardation (ICF-MR) 
program was established to allow for some federal funding for service recipients with 
mental retardation.  Prior to 1971, the IMD exclusion applied to all people under the age 
of 65 in any facility.  Nearly half of all people in state psychiatric hospitals under the age 
of 65, who were there for reasons other than mental illness, were mentally retarded.  This 
exemption to the IMD rule led to a decline in the number of patients with mental 
retardation in the state psychiatric hospitals (National Association of State Mental Health 
Program Directors, 2014, p. 11). 
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Later in 1972, people under the age of 21 were exempted from the IMD 
exclusion.  This led to an increase in child and adolescent hospital units.  In 1988, 
institutions with 16 or fewer beds also become exempted, which led to an increase in 
smaller residential treatment programs and psychiatric hospitals (National Association of 
State Mental Health Program Directors, 2014, p. 11). 
The Affordable Care Act of 2010 authorized Centers for Medicare and Medicaid 
(CMS) to fund a pilot project where non-government inpatient psychiatric hospitals could 
be exempt from the IMD exclusion, for purposes of providing acute psychiatric care to 
Medicaid patients age 21 to 64 (National Association of State Mental Health Program 
Directors, 2014, p. 11).  The new Medicaid reimbursement rule was finalized in April 
2016, partially repealing the IMD exclusion in non-government inpatient psychiatric 
hospitals (Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016, p. 3).   
The Affordable Care Act (ACA) of 2010 expanded access to mental health 
services through the expansion of Medicaid.  The ACA provides substantial federal 
funding for the states that choose to expand their Medicaid programs to include people 
with incomes up to 138% of the federal poverty level (Beronio, Glied, & Frank, 2014, p. 
411).  As of July 7, 2016, 19 states have not yet elected to expand Medicaid (Henry J. 
Kaiser Family Foundation, 2016).  This coupled with the reduction in federal Medicaid 
Disproportionate Share Hospital (DSH) payments, under the Bipartisan Budget Act of 
2013, may result in closure of beds or reduced community service funding.  As general 
hospitals begin to experience reductions in DSH funding, they will be more likely to 
close units with a high percentage of uninsured people, such as the psychiatric units.  
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This will increase demands on the state psychiatric hospitals (National Association of 
State Mental Health Program Directors, 2014, p. 23). 
Cost is a major barrier for receiving mental health treatment (Smith, Kuramoto-
Crawford, & Lynch, 2015).  Prior to the ACA, an estimated 12 million of the uninsured 
population had a diagnosable mental or substance use disorder.  Of the people who were 
insured, many had policies that either excluded behavioral health entirely or offered less 
comprehensive coverage of mental health needs compared to other general health care 
services (Beronio, Glied, & Frank, 2014, p. 411).  The Mental Health Parity and 
Addiction Equity Act of 2008 (MHPAEA), implemented in 2010, allowed for expansion 
of services by mandating that the financial and treatment requirements for mental illness 
and substance abuse disorders to be no more restrictive than those of medical/surgical 
benefits (National Association of State Mental Health Program Directors, 2014, p. 12).  
These healthcare reforms address some of the concerns regarding affordability by 
expanding insurance coverage, through inclusion of treatment for mental health and 
substance abuse as 1 of the 10 essential benefits eligible for coverage.  The MHPAEA 
has been shown to decrease out-of-pocket spending for certain mental disorders (Smith, 
Kuramoto-Crawford, & Lynch, 2015).  It is estimated that through the ACA and the 
MHPAEA together, with considerations of those states that will not expand Medicaid, 
that federal parity protections will be expanded to over 60 million Americans.  Over 30 
million will gain coverage that includes mental health and substance use disorder 
treatment, and an additional 30 million will see their existing coverage enhanced 
(Beronio, Glied, & Frank, 2014, p. 411). 
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The Health Information and Technology for Economic and Clinical Health 
(HITECH) Act of 2009 did not include state psychiatric hospitals and community mental 
health centers to be eligible for the same stimulus payments as general hospitals, which 
has led to many state psychiatric hospitals lagging behind on the implementation of 
electronic medical records (National Association of State Mental Health Program 
Directors, 2014, p. 12; Policymaking, regulation, & strategy Behavioral health, 2014). 
 States have been creative with determining ways to shift the care of psychiatric 
patients to the community, where some federal funds could be used.  This promotion of 
deinstutionalization has led to a decline in the number of psychiatric beds in state 
psychiatric hospitals.  Community services available still fall short of being able to 
accommodate the needs of people with mental illness, while access to the hospitals has 
become more and more limited.  This has led to increased use of emergency departments 
for acute psychiatric hospitals, a back-log of patients waiting in acute care hospitals for 
admission to state hospitals, and the number of people with mental illness living on the 
street or incarcerated (National Association of State Mental Health Program Directors, 
2014, p. 11). 
Data and Trends 
 NASMHPD and the NASMHPD Research Institute, Inc., (NRI) documented a 
shift in state government expenditures for mental health in the graph below.  In the 
1980s, nearly two thirds of expenditures went towards the state psychiatric hospitals as 
compared to community mental health.  In the early 1990s, the trend began to shift.  In 
2012, only 23% of resources were devoted to the state hospitals, with 74% going to 
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support community mental health (National Association of State Mental Health Program 
Directors, 2014, p. 14).   
Expenditures for the state psychiatric hospitals have continued to increase; 
however, there have been larger increases for community services.  State hospital 
expenditures increased from $3.9 billion in 1981 to $9.1 billion in 2012.  This reflects an 
average increase of 2.8% per year (National Association of State Mental Health Program 
Directors, 2014, p. 14).  See Figure 3 below (National Association of State Mental Health 
Program Directors, 2014, p. 14). 
Figure 3:   
 
(National Association of State Mental Health Program Directors, 2014, p. 14) 
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 In the 1950s, over 500,000 people were served in over 300 state psychiatric 
hospitals.  The state psychiatric hospitals were the primary source of public mental health 
services.  NASMHPD and the NASMHPD Research Institute, Inc., (NRI) documented 
the shift in number of state psychiatric hospitals and the number of residents in state 
psychiatric hospitals over the past 62 years.  The number of hospitals and patients has 
steadily declined, due to the deinstitutionalization and development of community mental 
health services.  The number of residents has declined by 92 percent over this time 
period.  The number of state psychiatric hospitals had declined by 36 percent as of 2012 
(National Association of State Mental Health Program Directors, 2014, pp. 14-15).  See 
Figure 4 (National Association of State Mental Health Program Directors, 2014, p. 14).  
Figure 4:
 
(National Association of State Mental Health Program Directors, 2014, p. 14) 
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 The average state psychiatric hospital has about 200 service recipients per day, 
reflecting that the size of the psychiatric hospital has declined more than the number of 
psychiatric hospitals.  States with multiple state psychiatric hospitals have closed some of 
their hospitals.  Figure 5 shows 14 states with only one state psychiatric hospital and nine 
states with 2 hospitals.  Rhode Island has state operated psychiatric beds within a state 
operated general hospital (National Association of State Mental Health Program 
Directors, 2014, p. 15).  Sixteen state hospitals in nine states had closed or merged from 
2010 to 2016.  By July 2015, there would be only 195 state hospitals in the US, down 
from 254 in 1997.  This reflects a 24% reduction in less than 20 years (Fuller, Sinclair, 
Geller, Quanbeck, & Snook, 2016, p. 7). 
Figure 5: Number of State Psychiatric Hospitals per State
 
(National Association of State Mental Health Program Directors, 2014, p. 15) 
 
 The recession of 2008 put great pressures on state-funded mental health services.  
As a result of reduced state government revenues, states made budget cuts that impacted 
	 31	
	
mental health services.  State mental health hospitals experienced budget cuts over $4.4 
billion between the recession of 2008 and 2013.  This led to bed closures in 29 states and 
hospital closures or considerations of closure in 15 states.  Over nine percent of state 
hospital beds were closed during this period (National Association of State Mental Health 
Program Directors, 2014, p. 16).  See Table 1 (National Association of State Mental 
Health Program Directors, 2014, p. 16). 
Table 1:
 
(National Association of State Mental Health Program Directors, 2014, p. 16) 
 
The number of state psychiatric hospital beds has fallen to the lowest in the past 
100 years (Dorwart, Schlesinger, Davidson, Epstein, & Hoover, 1991).  Approximately 
6000 beds were eliminated from 2010 to 2016, during a time when the US population 
grew by approximately 14 million people (Fuller, Sinclair, Geller, Quanbeck, & Snook, 
2016, p. 7).   
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In 1850, there were 14 beds per 100,000 people in the US.  In 2010, there were 
14.1 beds per 100,000 people, from a peak of 337 per 100,000 people in 1955.  Most 
recent data in 2016 reflects a ratio of 11.7 beds per 100,000 people (Fuller, Sinclair, 
Geller, Quanbeck, & Snook, 2016, p. 1).  When there are no accessible beds, people with 
mental illness end up in emergency rooms or living on the street, or worse yet in the 
criminal justice system (Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016, p. 1).  See 





































The Organization for Economic Cooperation and Development (OECD) ranked 
34 member nations by their total number of psychiatric beds.  The average was 68 beds 
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per 100,000 people in 2011.  The UNITED STATES ranked 29th, with only 25 combined 
state, county, general, community, and private psychiatric beds per 100,000 people.  New 
Zealand, Chile, Italy, Turkey, and Mexico provided fewer psychiatric beds than the US 
(Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016, p. 6). 
Care in state psychiatric facilities is funded primarily by state government funds.  
The IMD exclusion from 1965 effectively designated state governments to be responsible 
for the care of people with mental illness between the ages of 21 and 64.  The following 
table reflects the funding sources for treatment of psychiatric patients in state hospitals 
and community treatment (Treatment Advocacy Center, 2016).  State psychiatric 
hospitals are even responsible for the cost of caring for other comorbid, complex and 
expensive medical conditions that service recipients may have.  When people transfer 
into state hospitals from the court system, jails, and prisons, the state hospitals then take 
on the responsibility of their total medical care, not just the psychiatric illness.  This 
generally high cost and long-term care is primarily funded by the state (National 
Association of State Mental Health Program Directors, 2014, p.24; Treatment Advocacy 
Center, 2016).  See Table 3 (Treatment Advocacy Center, 2016). 
Table 3:   
 
Funding Sources for the Treatment of Psychiatric Patients in State Hospitals and 
Community Treatment 
 
 State Community 
State funds  
(include state Medicaid match) 
79% 55% 
Federal funds  
(mostly Medicaid and Medicare) 
16% 37% 
Local  
(county and city) 
1% 3% 
Other 4% 5% 
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Populations Served by State Psychiatric Hospitals 
 The population served in state psychiatric hospitals is variable across the states.  
The types of patients generally served include those who either do not respond well to 
medications or only partially respond, people who exhibit behavioral disorders and 
become violent, people who require intensive behavioral programming, people with a 
history of repeated violence or who exhibit self-destructive behaviors.  Others include 
those who need to be taken off of medications, those held for forensic reasons, and those 
identified as sexually dangerous (Hunter, 1999, p. 32).   
Most common services are geared toward the following populations:  adult, 
elderly, and forensic.  Some hospitals care for only forensic patients, while others care for 
a mixture of patient types within one hospital.  A smaller proportion of states have state 
psychiatric hospitals, which care for child and adolescent populations.  The overall 
population of service recipients includes people with mental illness, people with criminal 
behavior as a result of mental illness, and people with criminal and predatory behavior 
with no mental illness (National Association of State Mental Health Program Directors, 
2014, p. 16).  Among these are people with criminal justice involvement, a growing 
forensic population, sexual offenders, and the “difficult to discharge” population.  State 
hospitals must serve a broader range of patients than private hospitals (Fisher, Geller, & 
Pandiani, 2009, p. 679). 
 There are three categories for duration of care in state psychiatric hospitals:  acute 
care (less than 30 days), intermediate care (30 to 90 days), and long-term care (more than 
90 days).  Intermediate care is the most common, followed by long-term and then acute 
care.  Most acute care needs are now met in general hospitals (National Association of 
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State Mental Health Program Directors, 2014, p. 16).  See Table 4 (National Association 
of State Mental Health Program Directors, 2014, p. 16). 
Table 4:
 
(National Association of State Mental Health Program Directors, 2014, p. 16) 
 The number of service recipients in state psychiatric hospitals is variable by state.  
In 2012, there were at total of 40,305 service recipients in state psychiatric hospitals 
across the US.  California had the most service recipients at 6,016, ranging to a low of 50 
service recipients in Vermont.  The state average was 13.6 service recipients per 100,000 
population, ranging from a low of 3.7 per 100,000 in Arizona to a high of 46 per 100,000 
in the District of Columbia (National Association of State Mental Health Program 
Directors, 2014, p. 17). 
A Public Health Crisis 
State mental hospitals, once known as asylums, are remnants of a 19th-century 
reform movement to treat mental illness and to provide shelter and humane care for 
individuals with severe mental illness.  In the mid-20th century, state hospitals provided 
nearly 560,000 beds.  Since that time, a host of medical, social, political, and economic 
factors have aligned to reduce the bed population for adults with severe mental illness 
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(Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016).  Today, there is an increased use of 
emergency departments, for acute psychiatric crises, and shortfalls in the funding of 
community-based services.  This has led to a public health crisis for the mental health 
population – often leaving them to become homeless or incarceration (Sharfstein & 
Dickerson, 2009, p.685).  A study published by Kuno et al in 2000 found a homelessness 
rate of 24 percent among people with serious mental illness (Kuno, Rothbard, Averyt, & 
Culhane, 2000, p.1012). 
State hospitals today are a last resort for people who cannot be treated in the 
community.  37,697 staffed beds remain in state hospitals, representing a 17% reduction 
since 2010 and a 96.5% drop from peak hospital numbers in the 1950s.  Sixteen state 
hospitals in nine states closed or merged from 2010 to 2016.  In July of 2015, the number 
of state hospitals in the United States was 195, down from 254 in 1997, a 24% reduction 
in less than 20 years (Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016, p. 1).  
The theory behind downsizing the state psychiatric hospitals and 
deinstitutionalizing patients to the community was fundamentally sound.  Patients who 
could be treated in the community should be, as there was a time when conditions were 
poor in the hospitals and patients were left there with little hope of transitioning to the 
community.  The problem is that there are insufficient community services and funding to 
support people with severe mental illness.  Furthermore, approximately 25% of people 
with mental illness do not respond to treatment and are unable to live in the community 





A Call for Data 
The state psychiatric hospitals remain a fiscal burden on state governmental 
economies.  Their roles are very dependent on local and national trends, with funding at 
the mercy of the state governments – often beyond control of the administrators and 
agencies charged with running them.  The needs are many and the resources are few.  For 
example, many years of strained financial resources has left hospitals in a state of 
disrepair.  The cost of refurbishing old buildings must be weighed against the cost of new 
buildings – all competing with the costs to maintain and expand community-based 
services (Fisher, Geller, & Pandiani, 2009, p. 681).  State resources for mental healthcare 
services are limited, requiring state hospitals to operate as efficiently as possible, on all 
levels.  In order to direct scarce resources to areas of need, data is needed on costs, 
quality, and outcomes to completely assess the mental health system performance.  The 
Treatment Advocacy Center (2016) recommends improved data collection to inform 
public policy (Fuller, Sinclair, Geller, Quanbeck, & Snook, 2016, p. 3).  This quality 
improvement study will contribute to the body of knowledge about best practices being 
used to measure workload, staffing, and productivity metrics in state psychiatric hospital 
pharmacies, providing an additional tool to enable policy makers to better assess resource 
needs in state psychiatric hospitals. 
Pharmacy Services in State Psychiatric Hospitals 
 Pharmacy departments within state psychiatric hospitals, like those within general 
medical-surgical hospitals, are some of the most complex and heavily regulated 
departments within the healthcare system.  Pharmacy executives or directors are 
responsible for the strategic planning, design, operation, and improvement of the 
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organization’s management system.  Directors are responsible for advancing information 
technology, improving medication distribution systems, improving quality outcomes, and 
managing drug utilization, pharmaceutical procurement, financial performance, the 
pharmacy workforce, and ensuring regulatory compliance.  Decisions made by these 
leaders have the potential to profoundly impact patient care, patient safety, and the fiscal 
viability of the organization (American Society of Health-System Pharmacist, 2016, pp. 
329-332).  The paragraphs that follow will provide background on the required training, 
evolution of the pharmacist’s scope of practice, and various pharmacy service models 
that can be found in hospital pharmacy departments today.  More information is needed 
to understand how these trends translate into current practice across the nation in state 
psychiatric hospitals. 
Pharmacist Scope of Practice 
 Pharmacists practice in various settings, one of which is the psychiatric hospital.  
State laws regulate the practice of pharmacy, including the pharmacists’ licensure.  
Pharmacists must become registered or licensed to practice.  Licensed pharmacists 
graduate from an accredited college of pharmacy, including participation in internship 
programs, and must pass the National Association of Boards of Pharmacy Licensing 
Examination (NABPLEX).  Since 1992, most pharmacy schools offer the professional 
degree of Doctor of Pharmacy (PharmD). Most states require pharmacists to complete 
continuing education credits to maintain their license.  Many pharmacists go on to 
participate in residency programs and obtain board certification in specialty areas, 
including psychiatric pharmacy (American College of Physicians-American Society of 
Internal Medicine, 2002, p. 79; Crimson, et al., 1998, p. 1594).     
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 With the increase in automation used in pharmacy, many pharmacists are moving 
from traditional pharmacist roles of providing prescriptions to providing pharmaceutical 
care through clinical pharmacist roles.  As one author describes the transition, “Pharmacy 
has shed the apothecary role” (Hepler & Strand, 1990, p. 533), with the focus now being 
more patient-care oriented.  The American Pharmaceutical Association defines 
pharmaceutical care as being “patient-centered, outcomes-oriented, pharmacy practice, 
designed to promote health and prevent disease.”  Pharmacists transitioned from 
traditional roles of procuring, preparing, and selling medications of the early twentieth 
century to assessing, monitoring, initiating, and modifying medication use to assure that 
drug therapy regimens were safe and effective in the mid 1960s.  Today clinical 
pharmacists not only distribute drugs, but also monitor response and patient care 
outcomes, take drug histories, counsel patients and other health care professionals, 
conduct drug use evaluations, develop formulary services, participate as members of the 
care team to assess medication needs, prevent adverse drug events, develop patient-
specific therapies, manage chronic disease, and monitor follow-up care (American 
College of Physicians-American Society of Internal Medicine, 2002, p. 80; Hepler & 
Strand, 1990, p. 534; Jenkins & Bond, 1996, p. 713).  Since the advent of clinical 
pharmacy in the 1970s, the pharmacy profession has made a purposeful shift:  
“pharmacists are now dispensers of drug information and not solely dispensers of 
medicines” (Hanlon & Artz, 2001, p. 109). 
The Board of Pharmaceutical Specialties approved psychiatric pharmacy as an 
official specialty in 1992, after recognizing the growing importance of psychiatric 
pharmacy services (Canales, Dorson, & Crismon, 2001, p. 1309; Task Force on Specialty 
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Recognition of Psychopharmacy Practice, 1991, p. 1285).  Post-graduate training in 
psychiatric pharmacy is available in over 27 institutions in the US, with 21 having 
specialized 1-year residency programs, five with 2-year research fellowships, and two 
with combined residency graduate degree programs (Finley, Crismon, & Rush, 2003, p. 
1635; Stimmel, Psychiatric Pharmacy, 2013, p. 366).  Psychiatric pharmacists provide 
compassionate, respectful, confidential, cautious, and responsible care (Stimmel, 
Psychiatric Pharmacy, 2013, p. 366), having specialized knowledge in the following 
areas (Task Force on Specialty Recognition of Psychopharmacy Practice, 1991, p. 1288): 
• Pharmacology, including neuropharmacology 
• Toxicology 
• Social and behavioral pharmacy, including knowledge of rating scales 
• Pharmacokinetics 
• Pharmaceutical chemistry 
• Pharmaceutics 
The psychiatric pharmacy practitioner, or pharmacist specialized in psychiatric 
medication therapy, is uniquely qualified to ensure cost-effective use of antipsychotic 
medications; however, they are often underutilized (Stimmel, Psychiatric Pharmacy, 
2013, p. 366).   
Pharmacists work to maximize the therapeutic effect of medications, weighing 
cost against benefit.  Without such specialized pharmacists, there would be a higher risk 
of noncompliance, relapse, re-hospitalization, and increased potential for adverse drug 




Clinical pharmacists assess the patient, by reviewing the patient’s medical record 
to identify medication related issues.  They meet with the patient and caregivers to obtain 
complete medication histories, including assessment of medication adherence, allergies, 
and experiences with medication therapy.  They obtain, organize, and interpret patient 
data.  The clinical pharmacist identifies opportunities to optimize medication therapy 
through evaluation of the effectiveness, safety, and affordability of medications.  They 
work collaboratively with the care team to make interventions regarding medication 
therapy.  Pharmacists are trained to document their work directly in the patient’s medical 
record, regarding their efforts to optimize medication therapy and improve patient 
outcomes (American College of Clinical Pharmacy, 2014, pp. 794-97). 
 Clinical pharmacy services, such as clinical research, drug information services, 
medication administration histories, and participation on cardiopulmonary resuscitation 
teams, have been associated with reduced mortality rates in hospitals.  The following 
clinical pharmacy services have been associated with reduced total health care costs:  
drug use evaluation, drug information services, adverse drug report monitoring, drug 
protocol management, medical rounds participation, and medication admissions histories 
(American College of Physicians-American Society of Internal Medicine, 2002, p. 80).  
Studies in general medical settings have demonstrated that pharmaceutical services 
reduce medication costs, medication overuse, and adverse drug events (Canales, Dorson, 
& Crismon, 2001, p. 1309). 
Minimum Standards for Hospital Pharmacies 
 The American Society of Health-System Pharmacy (ASHP) has published 
guidelines, setting minimum standards for hospital pharmacies.  These guidelines are 
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helpful to evaluate the scope and quality of pharmacy services.  Per the guidelines, 
pharmacists shall be concerned about the outcomes of their pharmacy services, as well as 
the provision of pharmacy services.  The elements of pharmacy services found to be 
critical to providing safe, effective, and fiscally responsible medication use include: 
1. Practice management 
2. Medication-use policy development 
3. Optimizing medication therapy 
4. Drug product procurement and inventory management 
5. Preparing, packaging, and labeling medications 
6. Medication delivery 
7. Monitoring medication use 
8. Evaluating the effectiveness of the medication-use system 
9. Research 
Per ASHP, these core elements are linked to successful outcomes.  Failure to provide any 
of these elements could compromise the quality of patient care (American Society of 
Health-System Pharmacists, 2013, p. 498). 
Pharmacy Practice Models  
 The American Society of Health-System Pharmacists (2011) defines a pharmacy 
practice model as: 
How pharmacy department resources are used to provide patient care services.  
This includes how pharmacists practice and what services are provided in the care 
of patients, the role of pharmacy technicians in supporting patient care, and the 
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use of automation and technology in the medication-use process. (Woods, Lucas, 
& Robke, 2011, p. 259) 
The three most commonly used pharmacy practice models include:  (1) drug-distribution-
centered model, (2) clinical-specialist-centered model, and the (3) patient-centered 
integrated practice model (Woods, Lucas, & Robke, 2011, pp. 259-260).  The 
predominant pharmacy practice model in state psychiatric hospitals is unknown. 
 The drug-distribution-centered model is the traditional model, where pharmacy 
services are built around drug distribution, acquisition, and control.  Medication 
distribution and processing medication orders is the primary focus of the department.  
Pharmacists are rarely involved in proactive review of medication selection and 
monitoring.  Pharmacists generally work from the central pharmacy, with little 
integration with the health care team.  In such a model, with little clinical involvement, 
there may be limited need for pharmacists with advanced training.  Pharmacists and 
technicians often engage in similar duties, with pharmacists often performing tasks that 
could be completed by a technician.  Pharmacists have minimal accountability for patient 
care outcomes, other than timely and accurate delivery of medications (Woods, Lucas, & 
Robke, 2011, p. 259). 
 The clinical-specialist-centered model is similar to the drug-distribution-centered 
model, in that pharmacy services are generally provided from a central pharmacy location 
with most functions revolving around distribution and medication order verification.   It 
is different, because this model employs clinical pharmacy specialists who function 
independently of central pharmacy services.  They generally work up on the nursing 
units, where they round with the health care teams and perform clinical pharmacy 
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activities.  Typically, staff provides clinical services during the weekday and seldom on 
weekends and holidays.  There is often no coverage of clinical services during off hours.  
Pharmacists in these positions often have advanced training and credentials (Woods, 
Lucas, & Robke, 2011, p. 259). 
 The patient-centered integrated practice model has been found to be the most 
widely used practice model by ASHP (Woods, Lucas, & Robke, 2011, p. 260).  ASHP 
conducts national surveys of pharmacy practice in hospitals settings; however, their 
research excludes public, state psychiatric hospitals.  It is currently unknown whether the 
patient-centered integrated practice model is predominant in state psychiatric hospitals.  
In this model, all pharmacists have both distributive and clinical responsibilities.  This 
model depends on pharmacy technicians that are well trained and high functioning with 
regards to pharmacy distribution.  This allows the pharmacists to be freer to conduct 
clinical activities.  Pharmacists participate in interdisciplinary team meetings, proactively 
assist with evidence-based medication selection and monitoring, quality improvement 
activities, and development of therapeutic plans.  With this model, most all of the 
pharmacists on staff are able to do both clinical and distributive tasks.  Clinically 
competent pharmacists are available on all shifts, as compared to the clinical-specialist-
centered model where services are limited to the weekday.   Recruitment and retention of 
staff is generally best in organizations that offer this model, as pharmacists will not be 
limited to drug distribution activities alone.  This model has been reported to support the 
best high-quality patient care and to be more sustainable than the other two practice 




Clinical Pharmaceutical Services in Psychiatric Hospitals 
 The development of psychoactive medications in the 1950s really changed the 
management of people with mental illness (Task Force on Specialty Recognition of 
Psychopharmacy Practice, 1991, p. 1284).  These medications, along with the increasing 
public demand for quality patient care in state psychiatric hospitals and input from 
regulatory and standard-setting organizations, hospitals began to develop more 
comprehensive pharmaceutical services (McKee, 1991, p. 967).  Since the early 1970s, 
but more significantly in the past 20 years, the practice of pharmacy has been advancing 
from traditional drug distribution activities to a patient-oriented practice in mental health 
care settings (Kohan, 1973, p. 164; Zolezzi, Gottstein, & Nilsson, 2015, pp. 18-19).  
Pharmacists were traditionally thought of as only medication dispensers; however, 
pharmacists today are a vital part of the health care team (Cohen, 1999, p. 54).   
As early as 1977, the responsibilities of the mental health pharmacist were 
defined to include, not only drug distribution, but drug therapy monitoring, drug 
consultation, drug counseling, drug related education, formulary management, and 
overseeing transitions of care from the inpatient to outpatient setting (Stimmel, 1977, p. 
71; Cohen, 1999, pp. 54-57).  Studies that have evaluated the impact of adding a clinical 
pharmacist to existing staff have reported patient care benefits, including reductions in 
long-term drug therapy, reduced use of psychotropic and sedative-hypnotics, and cost 
savings; however, none of the studies looked at specific pharmacist functions, pharmacist 
time, process, costs, and outcome measures in the same study (Jenkins & Bond, 1996, p. 
713).  See Table 5 for a listing of clinical pharmacy services documented in the literature.  
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Table 5 includes services provided by hospital clinical pharmacists, either in acute care 
hospitals or psychiatric hospitals.   
Historically, budgets of mental health facilities have been limited since they are 
funded out of the same budget that funds education, roads, Medicaid, and other health 
programs also requiring public funds.  As a result, many of the roles involved in 
providing care to mentally ill people, are pushed down to a variety of disciplines other 
than the psychiatrist, with the psychiatrist providing limited direct patient care contact.  
The patient’s assigned therapist, psychologist, social worker, nurse, or aide frequently 
does medication evaluation and maintenance.  These other disciplines will assess 
medication response and adverse effects and report this to the psychiatrist, who then 
writes the medication orders.  This is the nature of a health care system with limited 
financial resources.  Having the clinical pharmacist work with the psychiatrist to assess 
medication related issues has been found to maximize drug therapy in mental health 
facilities, while allowing these other disciplines to focus on their areas of expertise 
(Stimmel, 1977, p. 71). 
Clinical pharmacists serve an important role to educate patients and their families 
on medications (Stimmel, 1977, p. 71).  They often teach classes as a component of the 
patient’s treatment programs.  Medication compliance is very important and particularly 
challenging in patients with mental illness.  With the emphasis on transitioning out of the 
hospital and back into the community for treatment, it is imperative that patients 
understand the reasons why they are taking their medications, for what symptoms the 
medications should be helpful, and which common adverse effects they should expect to 
have (Stimmel, 1977, p. 73).  Due to the nature of mental illness, education is commonly 
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provided to caregivers or guardians.  Although the concepts to be taught are not unique to 
mental illness, it often takes the pharmacist longer to provide education then it would to a 
different patient population. 
Psychiatrists and nursing staff actually make up a smaller proportion of staff in a 
psychiatric hospital; however, most patients take medications.  Psychologists, psychiatric 
social workers, occupational therapists, recreational therapists, and aides out number 
clinical staff.  This makes the pharmacist a key resource for medication and medically 
related issues (Stimmel, 1977, p. 71). 
Table 5:   
 
Sample of Clinical Services Provided by Hospital Pharmacists 
 
Admission medication histories 
Answer drug information questions from patients and members of the multidisciplinary 
care team 
ASHP-accredited residency training site 
Clarify orders 
Clinical inservice training for pharmacists 
Coordinate use of drug assistance programs 
Coordination of investigational drug use 
Discharge medication counseling 
Disease management 
Document all suggestions and interventions in the medical record 
Drug regimen review 
Drug use evaluation 
Formulate and implement an individualized medication therapy plan 
Inservice training for technicians 
Monitor adverse drug reactions 
Monitor dosage on all orders 
Monitor dosage route on all orders 
Monitor dosage schedule on all orders 
Monitor drug allergies 
Monitor food-drug interactions 
Monitor therapeutic duplication 
Participate in discharge education 
Participate on rounds with multidisciplinary care team  
Patient interview 
Perform medication profile and record reviews  
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Perform ongoing patient assessments to monitor medication therapy 
Pharmacokinetic monitoring 
Pharmacy clerkship or internship site 
Pharmacy newsletter 
Presentation of drug regimen recommendations to care team or physician 
Provide patient education before discharge 
Provide seamless care at discharge or transfer 
Quality assurance 
Resolve drug-related problems identified by staff in the dispensary 
Screen and monitor for drug-drug interactions 
Target drug program 
Teaching of medication classes 
Telephone follow-up after discharge 
TPN team participation 
(Zolezzi, Gottstein, & Nilsson, 2015, p. 51; McKee, 1991, p. 971; Finley, Crismon, & 
Rush, 2003, p. 1636; Schumock, Butler, Meek, Vermeulen, Arondekar, & Bauman, 2003, 
p. 117; Kaboli, Hoth, McClimon, & Schnipper, 2006, p. 957; Bond & Raehl, 2007, p. 
484) 
 
Impact of Pharmacists in Mental Health 
 Clinical pharmacists have been involved in mental health care settings for over 30 
years (Finley, Crismon, & Rush, 2003, p. 1635).  Over this time, there have been major 
advancements in the field of neuropsychopharmacology, which have led to the 
development of newer drugs with improved efficacy, safety, and tolerability (e.g., 
atypical antipsychotics, selective serotonin reuptake inhibitors, alternative mood 
stabilizers, and long-acting injectables).  With the increased use of these expensive and 
complex medications,  the value of clinical pharmacy services to help ensure the safety 
and efficacy of these medications have been called upon as a means to improve patient 
outcomes in a fiscally responsible manner.  The role of the pharmacist has grown well 
beyond traditional dispensing services (Finley, Crismon, & Rush, 2003, p. 1635), yet the 
impact of this growth on staffing levels is unknown.  Psychiatric pharmacy has been 
recognized as a unique specialty practice area within the field of pharmacy, noting the 
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need for specialized knowledge, functions, education, training, and transmission of 
knowledge in this care setting (Finley, Crismon, & Rush, 2003, p. 1636). 
 Research shows that pharmaceutical services can greatly reduce the total cost of 
care, length of hospitalization, contribute to improved clinical outcomes, and better 
patient care in general medical hospitals (Hepler & Strand, 1990, p. 537; Virani & 
Crown, 2003, p. 159; Kaboli, Hoth, McClimon, & Schnipper, 2006, p. 955; Gillespie, et 
al., 2009, p. 894).  Studies have shown that having a pharmacist participate on rounding 
teams in general medical hospitals reduces preventable adverse drug events by 78% 
(Kucukarslan, Peters, Mlynarek, & Nafziger, 2003, p. 2016).  Pharmacists assist by 
intervening to recommend dosage adjustments, to add or delete medications to therapy 
plans, monitoring laboratory values, identifying potential problems that may be 
encountered at discharge with regards to patients being able to procure medications.  This 
is done much easier, when the pharmacist is proactively involved with the health care 
team (Kucukarslan, Peters, Mlynarek, & Nafziger, 2003, p. 2017). 
Limited scientific investigations have been published, which quantify the 
outcomes of pharmacist-provided clinical services for patients with mental illness 
specifically.  Published studies regarding clinical pharmacists’ impact on prescribing in 
acute psychiatric facilities,  have found the potential cost savings from clinical pharmacy 
interventions to be substantial.  Prospective monitoring and medication counseling by 
pharmacists is effective in promoting appropriate drug use and decreasing 
rehospitalization (Saklad, Ereshefsky, Jann, & Crismon, 1984, p. 634).  Studies have 
demonstrated that clinical pharmacists can positively impact patient outcomes in pediatric 
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mental health populations, by decreasing drug expenditures (Virani & Crown, 2003, p. 
162). 
Finley (2003) performed a systematic review evaluating the quantity and quality 
of the medical literature examining the impact of pharmacists in mental health from 1972 
– 2003.  Thirty-five publications were identified; however, only sixteen were of sufficient 
scientific rigor to be included in the review.  The results of the sixteen studies were 
positive, having demonstrated improvements in outcomes, prescribing practices, patient 
satisfaction, and drug acquisition costs or days of hospitalization. The researchers 
concluded that additional multicenter cost-effectiveness trials are needed to further 
support the role of the psychiatric pharmacist (Finley, Crismon, & Rush, 2003, p. 1634).  
Jenkins and Bond (1996) published a literature review of contributions of clinical 
pharmacists to the care of psychiatric patients from January 1966 through January 1995.  
A majority of the twelve studies documented the positive effects of clinical pharmacy 
services on patient outcomes, such as improved care, improved level of functioning, and 
reduced medical and pharmaceutical costs.  Their conclusion was that a significant body 
of knowledge supports the pharmacist’s role in the care of psychiatric patients (Jenkins & 
Bond, 1996, p. 708) 
Clinical pharmacy services are appreciated for their ability to have a great 
financial impact, with regards to reducing healthcare resource utilization and costs 
(Anderson & Schumock, 2009, p. 544).  Studies that have evaluated the cost of 
incorporating clinical pharmacists have generally demonstrated a net hospital cost benefit 
in terms of cost avoidance and medication use (Kaboli, Hoth, McClimon, & Schnipper, 
2006, p. 963).  
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Although not specific to mental health, the economic benefit of pharmacy services 
was studied in 59 studies published from 1996-2000.  Researchers found the overall 
benefit:cost ratio was very favorable (median of 4.68:1 in 16 studies).  For every dollar 
invested in clinical pharmacy services, more than four dollars in benefit was expected 
(Schumock, Butler, Meek, Vermeulen, Arondekar, & Bauman, 2003, pp. 117, 120).  A 
benefit:cost ratio of 6.03:1 was reported in a government hospital study, which evaluated 
the effect of clinical pharmacy services on health care outcomes (Schumock, Meek, 
Ploetz, & Vermeulen, 1996, p. 1193).  As demonstrated in Table 6, different pharmacy 
services carry different benefit to cost ratios (Anderson & Schumock, 2009, p. 542).  
Cost-effectiveness can be improved by identifying pharmacist duties most beneficial to 
patients and determining whether less skilled and costly personnel can perform other 
duties (Kaboli, Hoth, McClimon, & Schnipper, 2006, p. 963). 
Table 6: 
Ranking of clinical pharmacy services by benefit-to-cost ratio 
In-patient clinical pharmacy service Benefit-
to-cost 
ratio 
Adverse drug event avoidance 92.00:1 
Drug therapy modification 34.61:1 
Antiepileptic management 33.68:1 
Drug therapy modification 22.99:1 
Heparin management 21.40:1 
Warfarin management 6.92:1 
Aminoglycoside pharmacokinetic monitoring 4.89:1 
Hypercholesterolemia intervention 4.81:1 






Staffing, Workload, and Productivity Metrics  
 State psychiatric hospitals have historically been challenged with considerable 
economic pressures due the structure of funding by state governments, on top of rising 
personnel and technology costs.  Recruiting qualified personnel continues to be a 
challenge as salaries often lag behind those in the private sector.  The pharmacy 
departments realize these same pressures.  Insufficient funding jeopardizes adequate 
pharmacy staffing, clinical program development, and advancement of personnel.  With 
these challenges, it is imperative that pharmacy leadership measures and studies 
pharmacy staffing, workload, and productivity with the goal of ensuring proper allocation 
of scarce resources to provide high quality services (Schumock, Walton, Sarawate, & 
Crawford, 2003, p. 666).   
Per ASHP guidelines for minimal standards in hospitals, as a means to evaluate 
the effectiveness of the medication-use system, a process shall exist to routinely monitor 
and document workload and financial performance, including the full scope of patient 
care services provided by pharmacists (American Society of Health-System Pharmacists, 
2013, p. 505).  Productivity tracking is becoming a necessary part of departmental 
budgeting, as leaders face the need to control rising drug costs in an era of budget cuts 
(Pawloski, Cusick, & Amborn, 2012, p. 49). 
Pharmacy Workload and Productivity Metrics are Difficult to Measure 
Efforts to develop systems to measure hospital pharmacy productivity date back to 
the early1960s (Gupta S. R., et al., 2006, p. 1728; Bartscht, Estrella, & Rothenbuhler, 
1965).  The purposes to study staffing and productivity metrics as defined in 1965, are 
similar to the needs of today (Bartscht, Estrella, & Rothenbuhler, 1965, p. 566): 
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1. To evaluate present staffing levels of hospital functions. 
2. To supply guidelines for staff adjustments resulting from changes in workloads, 
equipment, methods, procedures, policies, etc. 
3. To provide hospital administrators and supervisors with information for 
improving manpower budget and staffing reports. 
4. To provide a procedure for forecasting future staffing needs. 
In 1975, ASHP along with the American Hospital Association (AHA) developed the 
Hospital Administration Services program to report workload measurement.  
PharmaTrend, a productivity monitoring system, was also developed by ASHP.  A 
program called CliniTrend was eventually developed from PharmaTrend; however, none 
of these systems ever took off and are no longer available.  Pharmacy workload and 
productivity is difficult to quantify, because there are so many different services 
provided, ranging from manufacturing and distribution to provision of direct patient care.  
Many of the functions are not routinely recorded in electronic systems and would rely on 
manual collection, which may be inefficient or impractical (Gupta S. R., et al., 2006, pp. 
1728-1729). 
 Data envelop analysis (DEA) has been defined in the literature as an alternative to 
the use of multiple output/input ratios to measure only product-related work, as is typical 
of pharmacy benchmark data.  DEA uses elaborate mathematical modeling to aggregate 
quality, clinical, and product related data into a single comprehensive measure that can 
then be used to compare an overall productivity measure to like facilities or departments 
(Schumock, Shields, Walton, & Barnum, 2009, p. 1660).  The use of DEA should be 
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further explored in the area of pharmacy, with more practical and accessible applications 
designed for use by pharmacy managers. 
National standardized methods for measuring pharmacy productivity have not yet 
been defined in the United States, nor have standardized optimal staffing and productivity 
metrics (Glazier & Malen, 2007, p. 2320; Gupta S. R., et al., 2006, p. 1729; Gupta S. R., 
et al., Association between hospital size and pharmacy department productivity, 2007, p. 
937).  There continues to be growing concern within pharmacy about how best to 
evaluate staffing and resource allocation needs without adequate methods to measure 
workload and productivity (Gupta S. R., et al., Association between hospital size and 
pharmacy department productivity, 2007, p. 937). 
When considering pharmacy productivity metrics for state psychiatric pharmacy 
departments, most metrics measured in acute care hospitals would be applicable to state 
psychiatric pharmacy.  The measures may not be comparable, but the actual metrics to be 
measured would be.  It is important to understand that state psychiatric hospitals 
primarily focus on the psychiatric needs of the patients they serve.  Psychiatric hospitals 
often include a medical service; however, most complicated medical needs are referred to 
an acute care hospital for management.  Psychiatric hospitals do not generally include 
surgical services, labor and delivery services, or typical medical emergency services, 
which would be found in an acute care hospital.  Most medications dispensed in 
psychiatric hospitals are in oral formulations, with more limited amounts of intravenous 
medications compared to an acute care hospital.  Education provided to patients and their 
guardians may take longer to provide than it would to a general medical/surgical 
population in an acute care hospital.  In general, pharmacy services provided are of a 
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different nature than those provided in an acute care hospital making the acute care 
hospital pharmacy department a less than optimal comparison group for external 
benchmarking; however, much can be gleaned from how pharmacy metrics are studied 
and evaluated in acute care pharmacy. 
There is a lack of widely adopted productivity measurement methods for the 
profession of pharmacy.  Measuring pharmacy department workload and outcomes of 
non-distributive functions are known challenges; however, most hospital pharmacies 
collect some form of internal data for longitudinal benchmarking.  Access to data for 
external benchmarking is extremely limited (Rough, McDaniel, & Rinehart, 2010).  
Similar data from psychiatric hospital pharmacies is even more limited. 
The ASHP conducts a national survey to define pharmaceutical services in acute 
care hospitals, and publishes pharmacy metrics on prescribing, transcribing, dispensing, 
administration, monitoring, and patient education.  These reports include data on 
pharmacist and pharmacy technician staffing levels, categorized by the number of staffed 
beds, with the most recent data being reported in 2015 (Pederson, Scheider, & 
Scheckelhoff, ASHP national survey of pharmacy practice in hospital settings: 
prescribing and transcribing - 2013., 2014; Pederson, Schneider, & Scheckelhoff, ASHP 
national survey of pharmacy practice in hospital settings: dispensing and administration - 
2014., 2015; Pederson, Schneider, & Scheckelhoff, ASHP national survey of pharmacy 
practice in hospital settings: monitoring and patient education - 2012., 2013).  This data is 
valuable to hospital pharmacy administrators; however, the data were specific to acute 
care hospitals.  This same type of data would be applicable to psychiatric hospitals, yet 
these facilities were excluded.   
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No current external metrics and benchmarks for pharmacy staffing, workload, and 
productivity for psychiatric hospitals have been published.  The only study identified in 
psychiatric hospitals was based on data collected in 1989.  The objective of the study was 
to establish a database of information on the number and types of pharmaceutical services 
offered in psychiatric hospitals in 1989.  Unlike the proposed study described in this 
paper, the data included both private and public hospitals in the sampling frame.  A 
survey was conducted via mail of psychiatric hospitals across the United States.  The 
investigator surveyed a random sample of 200 out of 600 psychiatric hospitals registered 
by the American Hospital Association.  The study reported a 57% response rate, with 
responses categorized by hospital size, ownership status, geographic region, and average 
length of stay.  The investigators found substantial differences between government and 
nongovernment hospitals in the number and types of pharmaceutical services provided.  
Nongovernment hospitals appeared to offer more progressive pharmacy services.  
Hospitals in the western states offered more advanced clinical pharmacy services.  The 
mean number of pharmacist FTEs per respondent hospital was 3.5.  This varied by bed 
size of the hospital, with the mean number of pharmacist FTEs reported to be 1.6 per 100 
licensed beds.  The mean number of technician FTEs per respondent hospital was 2.4 and 
the mean number of technicians per 100 licensed beds was 1.3.  A noted limitation of the 
study was that the number of occupied beds was not collected in the survey instrument.  
Occupied beds would have been a better measure of actual productivity, as the number of 
license beds does not always reflect the number of beds being staffed (McKee, 1991, pp. 
967-968, 973).   
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Staffing studies conducted by consultant firms are very popular in healthcare 
organizations today; however, consultant firms do not publish their benchmark data for 
general use.  Benchmarks used by consultant firms are not accessible in the published 
literature.  Such studies are intended to cut costs, raise quality, improve service, and 
increase productivity (McAllister III, 1995).  Consulting organizations specialize in 
hospital operational benchmarking, by generally comparing staffing and workload ratios 
(Gupta S. R., et al., 2006).  When only doses dispensed are used to make these 
comparisons in hospital pharmacy, workloads in other areas fail to be measured (Gupta S. 
R., et al., 2006).  There are reports in the literature of hospitals, which have created and 
implemented data-driven staffing-to-demand models for pharmacy, which utilize hospital 
census, pharmacy workload, actual hours worked, and budgeted hours worked to 
determine a staffing matrix for when to flex staffing (Krogh, Ernster, & Knoer, 2012, p. 
1574).  This type of staffing model is more common in nursing, than pharmacy. 
There is a need to examine and improve how pharmacy department resources are 
deployed to address the needs of patients in state psychiatric hospitals. Clinical pharmacy 
services have been found to offer benefits in excess of costs; however, due to relatively 
high salaries and perhaps the history of the state psychiatric hospital, pharmacy personnel 
continue to be the object of staffing reductions (Anderson & Schumock, 2009, p. 539).   
History of the Workforce in the State Psychiatric Hospital 
 It is important to understand that historically, minimal federal and state 
regulations allowed the state psychiatric health care industry to evolve using primarily a 
minimum wage untrained workforce.  Professionally trained clinicians were few in 
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number, including pharmacists.  High staff turnover and inadequate training of direct-
care staff plagued the health system from the beginning (Hunter, 1999, pp. 29-30).   
By the mid-1970s, states began replacing clinical leaders with politically 
appointed public administrators.  As more political control was exerted, administrators 
generally carried out the will of the political leaders, regardless of the impact on the 
quality of patient care (Hunter, 1999, pp. 29-30).  Hunter (1999) sites a deputy 
commissioner as stating once in a meeting of a facility’s medical directors “facility 
budgets are not based on quality and what is needed.  Budgets are based on what the 
governor wants to give us, and the governor does not want to give mental health more 
money” (p.30).  Another example provided by Hunter (1999) was from a state mental 
health commissioner as he addressed his entire executive staff, including the state 
hospital superintendents, when presenting the budget for the upcoming year: 
We should have gotten more [money] but the governor said it would not get better 
than this.  Don’t get trapped in any local group’s efforts to increase the budget.  It 
won’t happen.  Don’t poor mouth this budget!  Say only fantastic [explicative] 
things about this budget.  Say only this is the best budget ever.  Don’t get trapped 
by the media.  Work your union folks so they can see how great a budget this is.  
Tell them we should not see any facility closures for the next decade.  Don’t 
obsess about where we’ve been [significant downsizing].  Don’t build controversy 
into this budget. (p.30) 
As clinical superintendents were replaced with politically appointed administrators, the 
quality of programming reportedly suffered.  Hunter documents that a high-ranking 
official in a state commissioner’s office once ordered hospital superintendents to lay off 
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the desperately needed direct-care staff and to replace them with members of a labor 
union who represented truck drivers.  Such direction demonstrates the failure of checks 
and balances between political power and social need (Hunter, 1999, pp. 30-31). 
 A 2014 NASMHPD report states a “well trained, professional and 
paraprofessional workforce is paramount in ensuring quality care.”  Without adequate 
staffing, the following indicators of inadequate professional staffing, training, and 
treatment programming may present:  (1) inappropriate use of psychiatric polypharmacy, 
(2) seclusion and restraint, and (3) involuntary medication use.  State psychiatric 
hospitals cannot maintain safe environments and provide effective treatments with 
perpetually high vacancy rates of professional staff and lack of staff training.  Staff 
vacancies are often an indicator of under-funding, coupled with non-competitive salary 
ranges (National Association of State Mental Health Program Directors, 2014, p. 36).  
NASMHPD has not defined pharmacy staffing specifically as being “paramount,” but the 
significance should be inferred. 
A national study of psychiatric care published in 1991, also reported that staffing 
metrics were an indicator of the quality of inpatient care.  Researchers demonstrated that 
over the ten-year period of 1978 to 1988, there had been significant decreases in the ratio 
of patients to professional staff in inpatient units of both private and public psychiatric 
hospitals.  (Professional staff was noted to include psychiatrists, psychologists, social 
workers, and registered nurses only.  Pharmacists were not studied.)  Researchers 
reported that overall, public psychiatric hospitals had relatively fewer professional 
personnel and used more nonmedical providers (Dorwart, Schlesinger, Davidson, 
Epstein, & Hoover, 1991, pp. 207-208). 
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Understanding this history is important, when trying to understand where the state 
psychiatric hospital is today.  It would be interesting to learn if the state psychiatric 
hospital pharmacy departments continue to struggle with high staff turnover, recruitment, 
and retention issues. 
Number of Pharmacist and Pharmacy Technician FTEs 
Clinical pharmacist staffing and specific clinical pharmacy services in general 
medical-surgical hospitals have been associated with reduced mortality rates.  Mortality 
is recognized by health care professionals and the lay public as the clearest and most 
significant outcome measure in health care (Bond & Raehl, 2007, p. 482).  Staffing has 
also been associated with reduced drug costs per occupied bed, reduced total cost of care 
per occupied bed, decreased length of hospital stay, decreased medication errors that 
adversely affect patient care outcomes (Bond, Raehl, & Patry, Evidence-based core 
clinical pharmacy services in United States hospitals in 2020: services and staffing, 2004, 
p. 429).  Increased levels of hospital pharmacist staffing along with four clinical 
pharmacy services (clinical research, drug information, admission drug histories, and 
cardiopulmonary resuscitation team participation) has been found to be associated with 
severity-of-illness-adjusted mortality rates.  The major contributor to reduced mortality 
rates was found to be an increased number of clinical pharmacists per 100 occupied beds.  
This data is from UNITED STATES acute care, general medical-surgical hospitals (Bond 
& Raehl, 2007, pp. 481-484; Bond & Raehl, Clinical pharmacy services, pharmacy 
staffing, and adverse drug reactions in United States hospitals, 2006, p. 745).  Clinical 
pharmacist staffing is a significant indicator of quality and cost of care in US hospitals 
(Bond, Raehl, & Franke, Clinical pharmacist staffing in United States hospital, 2002, p. 
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1490).  See Figure 6 (Bond & Raehl, Clinical pharmacy services, pharmacy staffing, and 
adverse drug reactions in United States hospitals, 2006, p. 741).  Benchmark pharmacy 
FTE staff per 100 occupied beds has been reported in this data; however, current 
benchmarks are not available for state psychiatric hospitals. 
Figure 6: 
Association Between Clinical Pharmacy Staffing and Adverse Drug 
Reactions/Hospital/Year 
 
(Bond & Raehl, Clinical pharmacy services, pharmacy staffing, and adverse drug 
reactions in United States hospitals, 2006, p. 741) 
 
To spite the documented benefit of clinical pharmacy services, some 
organizations have not yet chosen to support expanded pharmacy functions, beyond 
traditional dispensing roles (Hepler & Strand, 1990, p. 534).  In the late 1980s, only 22% 
of psychiatric hospital respondents reported having at least one pharmacist on staff 
spending at least two thirds of his or her time in a clinical role and many smaller hospitals 
were found to have no pharmacy technicians (McKee, 1991, p. 971).  It is currently 
unknown the extent to which expanded functions are available in the state psychiatric 
hospitals or which pharmacy staffing model is most prevalent.   
In general medical-surgical hospitals, Pederson (2014) found the number of 
pharmacist full-time equivalents (FTEs) averaged 13.5 and varied by the size of the 
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hospital.  Larger hospitals had more pharmacist FTEs.  The average number of pharmacy 
technician FTEs was 12.0 and also varied by hospital size, with more technician FTEs in 
larger hospitals.  The average number of pharmacist FTE per 100 occupied beds was 17.8 
and the average number of technician FTE per 100 occupied beds was 16.  This also 
varied by hospital size, with smaller hospitals have more pharmacist and technician FTEs 
per 100 occupied beds (Pederson, Scheider, & Scheckelhoff, ASHP national survey of 
pharmacy practice in hospital settings: prescribing and transcribing – 2013., 2014, p. 
940).  Similar staffing metrics are not available for state psychiatric hospitals.  It could be 
a helpful exercise to compare staffing metrics in state psychiatric hospitals to those of 
acute care.  The differences in patient acuity and services provided could be limiting 
factors, which would likely not allow for a meaningful comparison. 
The literature reports that an average United States hospital in 2004 (based on an 
average daily census of 108.97+ 169.45 patients) would need to add a maximum of 3.32 
pharmacist full time equivalents (FTEs) to provide core clinical pharmacy services in 
2020 (Bond, Raehl, & Patry, Evidence-based core clinical pharmacy services in United 
States hospitals in 2020: services and staffing, 2004, p. 427).  This type of data is 
unknown for state psychiatric hospitals, as are benchmark statistics for how state 
psychiatric facilities are currently staffed.  One study was found regarding 
implementation of clinical pharmacists into more clinical roles in a psychiatric hospital in 
Edmonton, Canada, which reported a goal staffing ratio as 1:35 for clinical pharmacists 
to patients for acute care units and 1:76 for nonacute care units (Zolezzi, Gottstein, & 
Nilsson, 2015, p. 52).  Similar recommendations were not found in other literature.  
Benchmark statistics are needed on pharmacy staffing in state psychiatric hospitals, 
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including number of pharmacist and technician FTEs, staffed hours per week, and how 
staff time is utilized. 
ASHP has collected staffing metrics for hospitals.  Again, the hospitals studied 
exclude public, state psychiatric hospitals. For acute care hospitals, data is available on 
pharmacist and pharmacy technician staffing levels, categorized by the number of staffed 
beds (Pederson, Scheider, & Scheckelhoff, ASHP national survey of pharmacy practice 
in hospital settings: prescribing and transcribing - 2013., 2014; Pederson, Schneider, & 
Scheckelhoff, ASHP national survey of pharmacy practice in hospital settings: dispensing 
and administration - 2014., 2015; Pederson, Schneider, & Scheckelhoff, ASHP national 
survey of pharmacy practice in hospital settings: monitoring and patient education - 
2012., 2013).  Given that there is a lack of objective standardized tools for determining 
reasonable pharmacist-to-patient staffing levels (Granko, Savage, Daniels, Smith, & 
Leese, 201, p. 1398), this type of benchmark data is valuable to hospital pharmacy 
administrators.  Unfortunately for psychiatric hospital administrators, specialty hospitals 
were excluded.  No current external metrics and benchmarks for pharmacy staffing in 
psychiatric hospitals have been published.  The last study identified was based on data 
collected in 1989 (McKee, 1991).   
Delivery of Interdisciplinary Care as a Measure of Quality 
 The Institute of Medicine (IOM) issued a report in 2001 titled Crossing the 
Quality Chasm:  A New Health System for the 21st Century.  This report cited medication-
related problems as a major patient-safety concern, especially in hospitals.  The report 
called for a fundamental redesign of the health care system as a means to reduce medical 
errors, which would include promotion of team-based practice models as the mainstay of 
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health care delivery.  The IOM reported that high-quality health care should be safe, 
effective, patient-centered, timely, efficient, and equitable.  There is a significant focus 
on the sharing of information between interdisciplinary team members and patients, 
including the pharmacist.  Studies have shown that well-coordinated, interdisciplinary 
care results in improved patient outcomes and greater efficiency for health systems.  
Pharmacist recommendations are more effective when made during the rounding process 
when medication therapy decisions are being made (Kohn, Corrigan, & Donaldson, 2000; 
Woods, Lucas, & Robke, 2011, p. 261; Kucukarslan, Peters, Mlynarek, & Nafziger, 
2003, p. 2017; Kaboli, Hoth, McClimon, & Schnipper, 2006, p. 955).   
Pederson (2013) reported from his survey research in general and children’s 
medical-surgical hospitals, that 38.1% of hospitals (77.4% of hospitals with 600 beds or 
greater) have pharmacists assigned to a majority of patients, eight hours a day, five days 
per week.  Pharmacist monitoring of most patients (>75% of patients) in hospitals has 
increased from 20.3% in 2000 to 46.5% in 2012.  Pharmacists have the authority to order 
laboratory tests and adjust medication dosages in more the 80% of hospitals and routinely 
perform discharge counseling in 24.7% of hospitals (Pedersen, Schneider, & 
Scheckelhoff, ASHP national survey of pharmacy practice in hospital settings: 
monitoring and patient education - 2012., 2013, pp. 787, 796).  Similar statistics for state 
psychiatric hospitals are currently unknown. 
 The type of pharmacy practice model deployed in state psychiatric hospitals, 
particularly the integrated pharmacy practice model, should be considered as an indicator 
of quality.  Having a practice model that ensures capable, competent pharmacists are 
	 66	
	
available at all times would be consistent with the IOMs call for high-quality, patient-
centered care (Woods, Lucas, & Robke, 2011, p. 261). 
Outcome Measures  
 Inpatients are at risk of poor health outcomes from adverse drug events and low 
utilization of evidence-based therapies (Makowsky, Koshman, Midodzi, & Tsuyuki, 
2009, p. 642).  Clinical pharmacy services in hospitals have been associated with 
improvement in mortality, drug costs, total costs of care, medication error and adverse 
drug reaction rates, length of stay, quality of drug therapy, process of care indicators, 
patient outcomes, and quality of life (Kaboli, Hoth, McClimon, & Schnipper, 2006, p. 
963; Bond & Raehl, 2007, p. 481; Makowsky, Koshman, Midodzi, & Tsuyuki, 2009, p. 
642).  Studies have found that team-based care, including a pharmacist, improved the 
overall quality of medication use and reduced readmission rates (Makowsky, Koshman, 
Midodzi, & Tsuyuki, 2009, p. 642).  The productivity of clinical pharmacists assigned to 
patient care units are often difficult to measure is generally listed as a limitation in studies 
reporting on pharmacy productivity measures.  There are no standardized tools to 
measure clinical productivity, making a comparison of the type of activities performed 
across other facilities or the amount of time involved a challenge (Pawloski, Cusick, & 
Amborn, 2012, p. 50).  Some general medical-surgical hospitals have developed their 
own methods to measure clinical productivity, such as using weighted metrics to quantify 
activities (Pawloski, Cusick, & Amborn, 2012; Granko, Savage, Daniels, Smith, & Leese, 




The National Clinical Pharmacy Services Survey, first issued in 1987, provides 
longitudinal data documenting these outcomes for pharmacists, public policy makers, and 
health system administrators.  Between 1989 and 2006, there has been a 300% increase in 
pharmacist-provided drug admission histories, 292.3% increase in pharmacist 
participation on rounds, 208% increase in hospitals that had pharmacist-provided drug 
protocol management.  The number of medication errors reported in hospitals increased 
by 151.4% between 1995 and 2006.  In 2006, 19.6% of hospitals had computerized 
prescriber order entry systems, 23.4% had bar coding for drug administration, and 39% 
used robotics for dispensing (Bond & Raehl, 2008, pp. 2,7).   
Measures of high quality performance include lower adverse event rates, lower 
mortality rates, more patient education, a broader array of services, and lower 
hospitalization rates (Rosenau & Linder, 2003, p. 184).  Adverse drug reactions were an 
outcome measure used in studies to demonstrate the value of pharmacist interventions in 
intensive care settings (Hanlon & Artz, 2001, p. 111).  
Performance can be defined and measured in many ways,  including the cost of 
care or the cost of medications.  Cost and efficiency may be measured as expenses per 
patient, cost per patient day, cost per case, net patient revenues, mark-up, or profitability 
(Rosenau & Linder, 2003, p. 184).  Table 7 below lists a sample of outcome measures, 







Table 7:   
Sample of Pharmacy Related Health Care Outcome Measures 
 
Mortality • Death rate 
Adverse drug 
reactions 
• Identification of frequency and severity of events 
• Prevention of events 
• Events requiring further treatment 
Medication errors • Medication errors that adversely affect patient outcomes 
• Identification of frequency and severity of events 
• Prevention of events 
• Events requiring further treatment 
Health services use • Annual hospital readmission rate 
• Admission and readmission rates because of complications 
• Transfer to more intensive care 
• Emergency department/urgent care use after discharge 






• Anticoagulation (time to therapeutic activated PTT or INR, time 
to the initiation of warfarin sodium therapy, time spent at 
therapeutic INR) 
• Pharmacokinetic dosing and drug monitoring (appropriateness 





• Number of medications  
• Medication appropriateness 
• Non-indicated medications 
Costs • Drug costs 
• Total cost of care 
• Expenses per patient 
• Cost per patient day 
• Cost per case 
• Net patient revenues 
• Mark-up 
• Profitability 
Other measures • Quality of life 
• Patient satisfaction 
• Medication adherence 
• Knowledge of medication regimen 
• Length of stay 
• Number of medications per patient 
• Number of doses administered per patient day 
• Number of anticholinergic prescriptions written for each patient 
(Kaboli, Hoth, McClimon, & Schnipper, 2006, p. 955; Bond & Raehl, 2008, p. 6; Cohen, 




 Quality measurement is fundamental to systematic improvement of the US 
healthcare system (Burstin, Leatherman, & Goldmann, 2016, p. 154).  The success of a 
health system and the health of its patients can be dependent on the performance within 
the pharmacy department.  It is imperative that pharmacy departments perform at the 
highest level possible, given the high cost of medications and drug-related technology, 
combined with the potential effects of adverse medication events and pharmacy services 
on patient outcomes and safety.  There is a lack of national systems for measurement, 
reporting, benchmarking, and improvement (Burstin, Leatherman, & Goldmann, 2016, p. 
154); however, strategies have been published that describe intricate algorithms designed 
to characterize pharmacy performance elements on the basis of feasibility, financial 
return, and effect on quality and safety.  This type of framework can be helpful for 
pharmacy departments to establish priorities in improving the medication-use system 
(Vermeulen, et al., 2007, pp. 1699-1700). 
The American College of Clinical Pharmacy (ACCP), through the National 
Clinical Pharmacy Services database referenced above, studies the growth of clinical 
pharmacy programs, medication error rates, and the implementation of pharmacy 
technology over time in United States hospitals.  Data is intended to guide hospital 
pharmacy directors in allocating resources to optimally meet patients’ needs.  It is 
important to note the survey is distributed to acute care general medical-surgical 
hospitals, including pediatric hospitals.  Specialty hospitals, including psychiatric 
hospitals, were excluded (Bond & Raehl, 2008, p. 2); therefore, pharmacy managers of 
state psychiatric hospitals must use extreme caution when trying to extrapolate findings 
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to their settings.  Similar data is needed for state psychiatric hospitals, which is the intent 
of this research project.    
Pharmacy Informatics 
 ASHP defines pharmacy informatics as the “use and integration of data, 
information, knowledge, and automation in the medication-use process to improve health 
outcomes.”  Such technology has the potential to reduce medication-related errors, 
improve practitioner performance, and reduce health care costs (Matsuura & Weeks, 
2009, pp. 1934-1935).  Automation has been found to improve dispensing efficiency and 
reduce the rate of dispensing errors (James K. L., 2013; James, et al., 2013, p. 92).  
Automation supports safe and efficient medication dispensing and distribution; therefore, 
it plays a key role in the medication use process (Fox, Pedersen, & Gumpper, 2015, p. 
636).  The impact of automation and informatics on pharmacist staffing levels is currently 
unknown. 
 ASHP conducted a national survey on informatics in 2007, which focused on the 
adoption of informatics and technology within the medication use process.  This survey 
broadly assessed the status of pharmacy informatics in all hospitals across the US.  
Unlike other ASHP national surveys referenced in this paper and those of Pedersen 
below, this survey included the entire population of hospitals, including specialty, 
federal, and Veterans Affairs hospitals.  Government specialty hospitals (not including 
the Veterans Affairs hospitals) represented only a small proportion of respondents (30 out 
of 1066).  Overall, 5.9% of hospitals had fully implemented EHRs in 2007.  None of the 
governmental hospitals that responded were found to have completely implemented 
EHRs in 2007 (Pedersen & Gumpper, ASHP national survey on informatics: assessment 
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of the adoption and use of pharmacy informatics in U.S. hospitals - 2007, 2008, pp. 2244-
2245, 2249).   
Per the ASHP national study, technology was found to be a part of each step of 
the medication use process, including prescribing, transcribing, procurement, dispensing, 
administration, monitoring, and patient education.  Technology assists to reduce 
variation, streamline the use of human resources, and improve the safety of the 
medication use process (Pedersen & Gumpper, ASHP national survey on informatics: 
assessment of the adoption and use of pharmacy informatics in U.S. hospitals - 2007, 
2008, p. 2244).  
The use of technology, including electronic health records (EHRs), has changed 
dramatically in general medical-surgical hospitals since then.  Federal incentives to 
implement these systems with the Health Information Technology for Economic and 
Clinical Health (HITECH) Act of 2009 have really forced the implementation of this 
technology (Pedersen, Schneider, & Sheckelhoff, ASHP national survey of pharmacy 
practice in hospital settings: Monitoring and patient education - 2015, 2016, p. 1307).   
The technology is expected to improve the efficiency and quality of health care and lower 
the cost of health services.  Eligible hospitals appear to be significantly adopting EHRs; 
however, psychiatric hospitals, which were excluded from the HITECH Act, are not.  
Adoption may be limited because of high costs, unknown return on investment, and 
implementation challenges.  This is unfortunate, because ineligible hospitals would likely 
share similar benefits from EHR systems (Walker, Mora, Demosthenidy, Menachemi, & 
Diana, 2016, p. 495).  See Figure 7 and 8 below (Walker, Mora, Demosthenidy, 
Menachemi, & Diana, 2016, p. 497; Wolf, Harvell, & Jha, 2012, p. 508).  Patients who 
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receive care at hospitals without EHRs will be less likely to benefit from the improved 
care associated with access to an EHR and the health care system overall will not realize 




(Walker, Mora, Demosthenidy, Menachemi, & Diana, 2016, p. 497) 
Figure 8: 
 
(Wolf, Harvell, & Jha, 2012, p. 508) 
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With the implementation of EHRs, the use of paper records has declined.  Per 
Pederson (2016), EHRs have been partially or completely implemented in 97.5% of 
hospitals, which responded to the survey.  This later survey represents data from general 
medical-surgical hospitals only.   
Computerized prescriber order entry systems with clinical decision support were 
used in 84.1% of hospitals, with barcode-assisted medication administration used in 
93.7% (Pedersen, Schneider, & Sheckelhoff, ASHP national survey of pharmacy practice 
in hospital settings: Monitoring and patient education - 2015, 2016, p. 1307).  Pederson 
(2014) reported smart pumps were used in 80.8% of hospitals and 93.3% of hospitals 
used electronic medication administration records (Pedersen, Scheider, & Scheckelhoff, 
ASHP national survey of pharmacy practice in hospital settings: prescribing and 
transcribing - 2013., 2014, p. 924).  
In 2015 the ASHP survey was updated, which included all hospitals.  In this data 
set, hospital pharmacies were found to have an average of 3.12 pharmacy information 
technology FTEs.  It is unclear from the study whether any governmental hospitals were 
included in the study.  Overall, 30.2% of hospitals had completely implemented EHRs in 
2013 (Fox, Pedersen, & Gumpper, 2015, p. 636).   
 The EHR may not have been as readily adopted among state psychiatric hospitals, 
because state psychiatric hospitals are not yet eligible to receive funding and incentives 
from the HITECH Act.  Barriers include the cost of implementing such technology, 
potential for privacy violations, and sustainability (Policymaking, regulation, & strategy 
Behavioral health, 2014).  Mental-health clinics, psychologists, and psychiatric hospitals 
were left out of the incentive and penalty program.  It is estimated that the cost to include 
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them would have been an additional $1 billion (Gillespie L. , 2015).  Much like the care 
of behavioral health needs continue to be left up to the states as described earlier, this 
population has yet again been carved out.   
 The use of electronic health records along with pharmacy-profiled automated 
dispensing cabinets has enabled remote pharmacy order review.  The amount of orders 
administered without pharmacist review has declined.  Smart phones and tablets are 
being used more commonly to access drug information and generate health information 
more efficiently (Pedersen, Schneider, & Scheckelhoff, ASHP national survey of 
pharmacy practice in hospital settings: monitoring and patient education - 2012., 2013, p. 
802). 
 Pederson (2015) found that 97% of general medical-surgical hospitals surveyed 
used automated dispensing cabinets to distribute medications.  21% of hospitals used a 
medication carousel to store medications in the pharmacy, which has increased from 11% 
in 2011.  44.8% of hospitals used some form of machine-readable coding to verify doses 
before dispensing in the pharmacy (Pedersen, Schneider, & Scheckelhoff, ASHP national 
survey of pharmacy practice in hospital settings: dispensing and administration - 2014., 
2015, pp. 1119,1121-122).  Similar benchmark statistics are currently unknown for state 
psychiatric pharmacy departments.  An analysis of pharmacy technology implementation 
and its effects on productivity in state psychiatric hospitals is recognized to be an area 
that warrants further investigation; however, it is beyond the scope of this study.  
Operational Benchmarking 
Operational benchmarking is a means to continuously measure and improve 
individual departmental performance and to evaluate success.  The term benchmarking is 
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defined as “finding and implementing the best practice” (Rough, McDaniel, & Rinehart, 
Effective use of workload and productivity monitoring tools in health-system pharmacy, 
part 1, 2010, pp. 300-301). Per Witt (2002), benchmarking “creates the context in which 
to identify issues, set targets, and take action to improve performance” (Witt, Practice re-
engineering through the use of benchmarks: Part 1, 2002, p. 191).   
The use of operational benchmarking is increasing within health systems as a tool 
for continuously measuring and improving individual departmental performance.  
External benchmarking can be helpful to find and implement best practices of peer 
organizations (Rough, McDaniel, & Rinehart, Effective use of workload and productivity 
monitoring tools in health-system pharmacy, part 1, 2010).   To cultivate success, health 
systems, including pharmacy departments, must measure performance of their operations 
against benchmarks and then apply that knowledge to performance improvement.  
Benchmarking provides a continuous process for measuring and learning about 
productivity, costs, and quality.  Benchmarks should be used to create accountability and 
drive performance to achieve the “best practices” standard (Witt, Practice re-engineering 
through the use of benchmarks: Part 1, 2002, p. 187). 
Internal benchmarking is most commonly found in practice (i.e., comparison of 
this years budget to last year); however, this is least helpful for re-engineering processes 
or improving performance.  Internal benchmarks are weak in their capacity to identify the 
critical drivers that lead to performance improvement.  To clarify factors that drive 
performance, it is important to use external benchmarks (Witt, Practice re-engineering 
through the use of benchmarks: Part 1, 2002, p. 188). 
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Industry benchmarking is a form of external benchmarking, which includes 
benchmarking against organizations in the same business, which is not competing for 
customers.  The advantages of this type of external benchmarking is that organizations in 
the same business (i.e. psychiatric hospitals) are faced with similar issues and or 
practices, with a similar willingness to share data, with potential to lead to best 
performance targets (Witt, Practice re-engineering through the use of benchmarks: Part 1, 
2002, p. 188).   
A particular challenge with industry benchmarking is that there may be unknown 
differences in the organizations, which should be considered (Witt, Practice re-
engineering through the use of benchmarks: Part 1, 2002, p. 188).  When choosing an 
organization to benchmark against, it is important to compare against an organization that 
is as similar as possible to avoid benchmarks that may not be relevant; however, it should 
be noted that differences in organizational characteristics do not necessarily invalidate a 
benchmark.  Performance targets should be established using both internal history and 
external benchmarks for guidance.  Benchmarks are not absolute and should only serve to 
provide direction to identify potential problems and solutions (Witt, Practice re-
engineering through the use of benchmarks: Part 1, 2002, pp. 189-190). 
External benchmarking can be helpful to find and implement best practices of 
peer organizations.  The Xerox Corporation first utilized benchmarking in the late 1970s.  
Xerox identified and implemented best practices from other industry leaders, with regards 
to measuring products, services, and practices, and improved organizational performance 
as a result (Rough, McDaniel, & Rinehart, 2010, p. 301).   
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More than ever before, health care executives must maintain a tight focus on the 
provision of high quality of care in the most cost effective manner possible.  As a result, 
the use of operational benchmarking is increasing within healthcare organizations, with 
hospital administrators expecting pharmacy directors to be able to monitor and articulate 
performance-related metrics, by constructively identifying shortcomings and 
opportunities for improvement (Rough, McDaniel, & Rinehart, 2010, pp. 300-301).  
High-performance pharmacy departments establish a metrics-based management culture, 
with a structured system of internal and external benchmarking, including ongoing 
comparative evaluation (Hicks, Swift, & Daniels, 2016, pp. 150-151).  While the 
pharmacy department shares a fiduciary responsibility to the organization’s economic 
viability, pharmacy directors must not lose sight of the overriding responsibility to 
provide quality pharmaceutical care.  Benchmarking should be approached with the goal 
of implementing best practices to minimize costs, raise quality, improve service, and 
increase productivity (McAllister III, Collaborating with re-engineering consultants: 
maintaining resources for the future, 1995, p. 2676).  
A trends report from the ASHP Research and Education Foundation reported in 
the 2016-2020 Pharmacy Forecast report that 68% of respondents thought it likely that at 
least 50% of health systems will use a dashboard to report pharmacy department 
performance on standardized quality indicators for comparison to pharmacy performance 
in similar health systems.  Measures should be based on improved patient outcomes and 
decreased costs.  ASHP explains that pharmacy leaders should collaborate with other 
health care systems to identify and standardize measures of pharmacy clinical and 
operational activities (Zeller WA, 2015, p. 24).  This research project will provide a 
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means for pharmacy leaders in state psychiatric hospitals to benchmark with departments 
of similar type and bed size. 
Pedersen (2016) reported that 69.7% of hospitals, which responded in a survey for 
general medical-surgical hospitals, used key metrics to measure performance.  The use of 
metrics varied by hospital size, with larger hospitals being more likely to use key metrics 
than smaller hospitals.  Use of the following administrative and operational metrics were 
reported: 
• Financial metrics (84.2%) 
• Pharmacists’ clinical interventions (73.7%) 
• Workload and productivity measures (72.5%) 
• Dispensing and distribution measures, including turnaround times, missing 
doses, and dispensing errors (54.5%) 
• Inventory measures, including shortages, stock outs, and turnover (52.7%) 
Quality and outcomes metrics were tracked as follows: 
• Healthcare Providers and Systems (HCAHPS) scores (64.5%) 
• National Quality Goals (e.g., National Patient Safety Goals) (58.5%) 
• Patient satisfaction (50.3%) 
• 30-day readmissions (48.2%) 
Medication Safety metrics were reported as follows: 
• Adverse drug events or medication errors reported by staff or patients (91.9%) 
• Technology utilization (e.g., bedside bar-coding reports) (86.4%) 




(Pedersen, Schneider, & Sheckelhoff, ASHP national survey of pharmacy practice in 
hospital settings: Monitoring and patient education - 2015, 2016, pp. 1322-1324). 
Challenges of Benchmarking  
Pharmacy directors should understand the necessity of using benchmarking and 
productivity monitoring to justify pharmacy operations and expansion of services 
(American Society of Health-System Pharmacists, 2005, p. 1305); however, the inability 
to effectively measure workload and productivity has been a long-standing problem for 
hospital pharmacists.  To date, there is no defined standard for measuring hospital 
pharmacy workload and staffing effectiveness.  Meaningful metrics are needed to 
evaluate the overall effectiveness and value of clinical pharmacy services (Rough, 
McDaniel, & Rinehart, 2010, p. 301; Rough, McDaniel, & Rinehart, Effective use of 
workload and productivity monitoring tools in health-system pharmacy, part 2, 2010, p. 
382).   
Software used for benchmarking purposes is extremely limited, and not very 
effective at measuring departmental operations and overall performance (Rough, 
McDaniel, & Rinehart, 2010, p. 300).  Systems are unable to accurately account for 
clinical pharmacy services performed by staff and are therefore unable to measure the 
overall value of pharmacy services in patient care.  There is no common documentation 
method for logging clinical pharmacy interventions, nor is there a common validated 
method to determine the economic impact of these interventions on an ongoing basis.   
This is particularly important as the pharmacy practice model evolves more into a 
cognitive-based profession (Rough, McDaniel, & Rinehart, Effective use of workload 
and productivity monitoring tools in health-system pharmacy, part 2, 2010, p. 385).  
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Since software systems lack a robust measure of quality care outcomes, balanced 
scorecards or dashboards should be used to incorporate indicators of quality into 
efficiency and effectiveness measures.  Internal benchmarking via dashboards and 
scorecards should be used to measure financial, workload, and quality indicators specific 
to the needs of the individual hospital over time (Rough, McDaniel, & Rinehart, 2010, p. 
303; Rough, McDaniel, & Rinehart, Effective use of workload and productivity 
monitoring tools in health-system pharmacy, part 2, 2010, p. 385-387). 
External benchmarking is informative only when it is used to compare similar processes 
or products (Rough, McDaniel, & Rinehart, 2010, p. 301).  External vendors, or 
consultants, often benchmark hospitals against a peer group, which may or may or may 
not be comparable.  Having a peer group is important, so that directors may benchmark 
metrics against hospitals of similar bed size and pharmaceutical services provided 
(American Society of Health-System Pharmacists, 2005, p. 1305).  The intent of this 
research is to collect data from hospitals of similar type, categorized by bed size.  Even 
with a peer group of state psychiatric hospitals, directors will need to consider differences 
that may exist within their own facility when making comparisons.  The number of 
differing services provided within departments will make accurate reporting and 
measurement difficult.  It is expected that the level of pharmacist involvement in clinical 
services amongst hospitals will be variable, as will the use of various technologies such 
as electronic health records, bed side barcoding, computerized prescriber order entry, and 
use of automated dispensing cabinets (Rough, McDaniel, & Rinehart, 2010, p. 305). An 
analysis of pharmacy technology and its effects on productivity will be beyond the scope 
of this study.  
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External vendors also struggle with selecting the right metrics to benchmark, 
including acuity, labor, cost, and productivity metrics.  For example, differences in 
patient acuity and the measurement of acuity should be considered when possible.  The 
pharmacy intensity score is preferred over the Centers for Medicare and Medicaid 
Services (CMS) Case Mix Index (CMI) score.  The pharmacy intensity score is a 
resource-based, relative value intensity grouping system, which uses pharmaceutical 
resource consumption data to produce DRG-specific drug-use requirements (Rough, 
McDaniel, & Rinehart, 2010, p. 306). 
Truven Health Analytics is an independent company, which offers a suite of 
products tailored for health systems to compare their organizations to comparable 
systems nationwide.  Pharmacy departments can use Truven to determine ideal staffing 
levels, optimize workload among their staff, and determine if drug costs are comparable 
to those of similar hospitals.  All of the limitations already discussed still apply to the 
Truven data set.  The availability of this data is only to those who are participating or 
contributing to the data pool.  The data set is generally from general medical-surgical 
hospitals, with extremely limited data from state psychiatric hospitals; however, hospital 
administrators may still try to apply the data, not fully understanding the limitations of 
the product (Carmichael, Jassar, & Anh, 2016, p. 1542). 
Benchmarking Process 
The benchmarking process generally occurs in two phases.  In the first phase, 
critical data points or drivers are identified that should be monitored.  External 
benchmarks should be sought for which to compare internal data.  Internal data is then 
gathered, variances to the standard are identified, and targets for improvement should be 
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determined.  In phase two, action is taken to implement change and monitor ongoing 
performance.  It should be noted that external benchmarks should serve as roadmaps or 
general guidelines for comparison, but not absolute determinants of how an individual 
hospital should perform (Witt, 2001, p. 67).  To date, state psychiatric hospital pharmacy 
department leaders are limited to general medical-surgical hospital data for comparison, 
which is arguably not a similar peer group.  The services provided in a general medical-
surgical hospital are very different than those of a specialized state psychiatric hospital.  
Key Indicators and Meaningful Metrics 
Ideally, effective benchmarking allows pharmacy administrators to identify 
opportunities for improving workflow efficiency, patient care services, and financial 
performance, with an overall improvement in value to the organization.   Without 
appropriate benchmarks, staffing and resource allocations may be made that negatively 
affect the safety and quality of the medication-use process (Rough, McDaniel, & 
Rinehart, 2010, p. 300).  
Pharmacy benchmarking should include both supply (or drug expense) and labor 
indicators.  There should be defined targets for regularly monitored financial and 
operational indicators (Hicks, Swift, & Daniels, 2016, p. 59).  Productivity and cost ratios 
should be used to measure departmental effectiveness.  Productivity ratios include 
metrics such as hours worked or hours paid per unit of output, such as discharges or 
orders processed.  Cost ratios include metrics such as dollars per statistic, such as drug 
expense per admission.  The most precise metric would include drug expense per 
admission per specific diagnosis-related group (DRG), with clinical outcomes reported 
(American Society of Health-System Pharmacists, 2005, p. 1305). 
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Per Rough (2010), vendor-reported labor- and cost-productivity ratios are often 
flawed and used inappropriately to compare hospital metrics.  There are many metrics 
that have been used.  See Table 8 (Rough, McDaniel, & Rinehart, 2010, p. 309).  Rough 
cautions against using measures based on doses charged or dispensed, because these do 
not fully measure the range of pharmacists’ activities and related patient outcomes.  It is 
recommended to evaluate labor efficiency using worked hours per 100 orders, worked 
hours per pharmacy intensity weighted discharge, and pharmacy labor expense per 
pharmacy intensity weighted discharge.  Suggested cost efficiency metrics include drug 
expense per pharmacy intensity weighted discharge and total pharmacy expense per 
pharmacy intensity weighted discharge.  Pharmacy directors should determine which 
labor productivity and cost metrics would be most applicable and useful in determining 
the effectiveness of their departments (Rough, McDaniel, & Rinehart, 2010, p. 310). 
It is recommended to measure pharmacy performance per admission rather than 
per patient day.  Per admission is reported to be better, because most intensive drug use 
occurs in the first few days of admission (Rough, McDaniel, & Rinehart, 2010, p. 310).  


















Examples From the Literature of Frequently Used Pharmacy Productivity Ratios 
 
(Rough, McDaniel, & Rinehart, 2010, p. 309) 
Meaningful Peer-Group Selection 
Current published benchmarks comparing hospital pharmacy staffing and 
workload ratios are limited to acute care, excluding psychiatric and behavioral health 
hospitals (Gupta, 2006; Pedersen, 2015).  The objective of this quality improvement 
study will be to develop current benchmark statistics for use in assessing workload, 
staffing, and productivity metrics used in hospital pharmacy departments of state 
psychiatric hospitals, categorized by hospital bed size. Use of these new benchmarks will 
allow pharmacy administrators to identify opportunities for improving workflow 
efficiency, patient care services, and financial performance, with the overall goal of 





Methods Used for Benchmarking Studies 
 Survey methodology is a very common means used to define metrics used for 
external benchmarking in pharmacy.  This methodology has been effectively applied in 
similar settings for similar types of research, which will be further described below.  
Surveys are typically self-administered and may be distributed either online or on paper.  
Respondents answer questions based on their knowledge.  Surveys are ideal, because 
many people are familiar with the process of completing a questionnaire, it is relatively 
low cost to distribute questionnaires either by mail or online, and survey results are easily 
tabulated.  One disadvantage that will need to be anticipated is that some recipients may 
not respond to the survey and some will fail to answer all of the questions (Fink, 2005, 
pp. 121-23), which could contribute to non-response bias.  
 The largest and most well known survey research conducted regularly in 
pharmacy is completed by the ASHP.  ASHP conducts national surveys each year to 
define pharmaceutical services in acute care hospitals.  The surveys are organized 
according to six components of the medication-use process: prescribing, transcribing, 
dispensing, administration, monitoring, and patient education.   Each year the survey is 
designed to focus on two components of the medication-use process and the results are 
published in the American Journal of Health-System Pharmacists.  The survey 
instruments collect data such as pharmacist and technician staffing levels, use of 
technology, provision of clinical pharmacy services, and how departments are meeting 
certain regulations.  Data are generally grouped by number of staffed beds to allow a 
pharmacy administrator to make a direct comparison to facilities of similar size.  These 
reports are regularly published to allow pharmacy administrators to benchmark against 
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metrics from facilities of similar type (Pedersen, Scheider, & Scheckelhoff, 2013; 2014; 
2015; 2016). 
 In each survey, ASHP researchers use questions from previous surveys that 
pertained to topics of interest in current surveys and evaluate the questions for clarity and 
response.  Data regarding hospital characteristics (i.e., number of beds, U.S. Census 
Bureau region and metropolitan statistical area, and ownership) were obtained from the 
IMS Health hospital database.  The sampling frame for these surveys are composed of 
general and children’s medical-surgical hospitals in the United States.  Specialty, federal, 
and Veterans Affairs hospitals were excluded from the sampling frame.  Hospitals were 
stratified by size before sampling and random samples were taken from each 
stratification.  For example, 1439 out of 7053 hospitals were randomly selected to send 
the survey to for completion (Pedersen, Scheider, & Scheckelhoff, ASHP national survey 
of pharmacy practice in hospital settings: prescribing and transcribing - 2013., 2014, pp. 
924-925; Pedersen, Schneider, & Sheckelhoff, ASHP national survey of pharmacy 
practice in hospital settings: Monitoring and patient education - 2015, 2016, p. 1308). 
 Respondents were offered a choice of completing a paper survey or an online 
survey (Pedersen, Schneider, & Sheckelhoff, ASHP national survey of pharmacy practice 
in hospital settings: Monitoring and patient education - 2015, 2016, p. 1308).  ASHP 
researchers contacted pharmacy directors up to six times during each survey period to 
encourage participation.  An announcement letter is sent by mail follwed by the first 
survey mailing two weeks later.  Respondents are not offered an incentive to respond to 
the survey.  Reminder postcards were mailed twice during the survey period and the  
survey were sent out an additional two times.  The final notice was made via telephone 
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(Pedersen, Scheider, & Scheckelhoff, ASHP national survey of pharmacy practice in 
hospital settings: prescribing and transcribing - 2013., 2014, p. 926; Pedersen, Schneider, 
& Sheckelhoff, ASHP national survey of pharmacy practice in hospital settings: 
Monitoring and patient education - 2015, 2016, p. 1308). 
Response rates reported in the ASHP national surveys were as follows: 34% in 
2012, 28.9% in 2013, 29.7% in 2014, and 22.7% in 2015.  This was much lower than the 
preferrable 50% noted in the literature for survey research (Shi, 1997, p. 170). 
 To facilitate data analysis, each hospital was assigned a unique identification 
number.  This allowed survey responses to be linked to the hospital characteristics in the 
IMS database.  To account for the sampling method used, weights were assigned to 
respondents to adjust their contribution to the population estimates.  Descriptive statistics 
were used extensively.  Chi-square tests and analysis of variance and regression were 
used to compare responses as a function of hospital characteristics.  The a priori level of 
significance was set at 0.05 (Pedersen, Scheider, & Scheckelhoff, ASHP national survey 
of pharmacy practice in hospital settings: prescribing and transcribing - 2013., 2014, p. 
926; Pedersen, Schneider, & Sheckelhoff, ASHP national survey of pharmacy practice in 
hospital settings: Monitoring and patient education - 2015, 2016, p. 1308). 
 Similar survey research has been completed on a smaller scale.  Gupta (2006, 
2007) issued a 50-item web-based survey to pharmacy directors across the nation who 
were members of a specified group purchasing organization.  Her surveys were  designed 
to gather data about systems of measuring hospital pharmacy productivity.  Data was 
collected on staffing levels within the pharmacy department as well as information about 
distributive and nondistributive pharmaceutical services provided by the department and 
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other workload data (Gupta, et al., Monitoring of pharmacy staffing, workload, and 
productivity in community hospitals, 2006, p. 1729).   
 The questionnaire was drafted and pre-tested by three individuals from the study 
population.  The sampling frame was defined by membership in the Consorta GPO and 
cross referenced against the AHA Guide.  Data excluded long-term care facilities, mental 
health facilities, psychiatric hospitals, nonacute care facilities, surgical centers, and other 
nonhospital facilities (Gupta, et al., Monitoring of pharmacy staffing, workload, and 
productivity in community hospitals, 2006, p. 1729). 
 Similar to the ASHP surveys, an email was sent to the directors of pharmacy at 
each facility requesting their participation and directing them to the web page where the 
survey would be completed.  Two separate emails were sent to non-responders at two-
week intervals (Gupta, et al., Monitoring of pharmacy staffing, workload, and 
productivity in community hospitals, 2006, p. 1729). 
 Data was downloaded into Microsoft Office Excel 2003 and recoded for analysis.  
Similar to the ASHP research, Gupta included data from an external database (AHA 
Guide) to describe hospital characteristics, such as number of staffed beds, number of 
admissions and outpatient visits, patient census, total expenses, and other demographic 
information (Gupta, et al., Monitoring of pharmacy staffing, workload, and productivity 
in community hospitals, 2006, p. 1729). 
 Descriptive statistics were used to profile responses and to characterize the 
sample.  Standard Student’s t tests and chi-square tests  were used to analyse the data.  
The overall response rate was 45.5% (110 hospitals responded), which was considerably 
higher than what was achieved in the ASHP surveys (Gupta, et al., Monitoring of 
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pharmacy staffing, workload, and productivity in community hospitals, 2006, pp. 1729-
1730). 
 Crawford (2013) completed a study utilizing a survey to characterize pharmacy 
practices and technologies used in critical access hospitals (CAHs) and other rural and 
small hospitals in Illinois.  A survey was sent to directors of pharmacy via mail at 86 
hospitals. CAHs were crosschecked through the Illinois Hospital Association.  Data were 
analyzed using independent sample t tests, Chi-square analysis, and Bonferroni-Holm 
adjustments.  The a priori level of significance was 0.05.  The response rate was 46.5% 
(Crawford, Schumock, Ursan, Walton, & Donnelly, 2013, p. 1314).   
Summary 
With the rising inflation of pharmaceuticals, driven by the increasing age of our 
population, advances in pharmaceutical technology, and strained economic resources, 
health care systems often turn their focus towards drug resource consumption as a cost 
containment strategy in health care systems (Schumock, Butler, Meek, Vermeulen, 
Arondekar, & Bauman, 2003, p. 123).  State psychiatric hospitals are not excluded.   
Regardless of significant literature demonstrating the value of clinical pharmacy 
services, pharmacy departments will continue to be impacted by across-the-board cuts, 
being asked again and again to “prove their worth” (Raehl & Bond, 2000, p. 459). 
Pharmacy leaders will continue to be challenged with the choice of reducing drug 
expenses or cutting labor costs.  Pharmacy managers must be able to understand their 
workload and productivity metrics, being able to both articulate and provide evidence of 
the value their departments provide, while being able to make wise decisions to make 
effective and efficient changes within their departments.   
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The objective of this literature review was to establish the background for the 
study and provide rationale for why this research will be an important addition to the 
current body of scientific evidence.  The history of the state psychiatric hospital is 
described, which explains why the state hospitals continue to be financially draining to 
the states.  State resources for mental healthcare services are limited, requiring state 
hospitals to operate as efficiently as possible.  In order to direct scarce resources to areas 
of need, data is needed on costs, quality, and outcomes to completely assess the 
performance of the state psychiatric hospital pharmacy department. 
 A thorough description of pharmacy services within state psychiatric hospitals is 
provided, as well as a discussion of the importance of operational benchmarking and 
potential quality improvement metrics.  Finally, methods used for similar benchmarking 







































Chapter Three: METHODOLOGY 
The objective of this study will be to develop benchmark statistics for use in 
assessing workload, staffing, and productivity in hospital pharmacy departments of state 
psychiatric hospitals.  The primary aims of the study will be to: 
Aim 1:  Secure collaboration and develop the sampling frame. 
Aim 2:  Collect benchmark data. 
Aim 3:  Analyze the results. 
It is hypothesized that hospital volume statistics, pharmacy expenditures, hours of 
operation, FTEs, and dispensing workload will vary based on the size of the facility.  
Staffing levels per bed will likely be highest for small hospitals. Small hospitals must 
staff to a minimum level of service and safety.  It is hypothesized that workload 
(dispensing, hours of operation, and clinical services) will be highest for large hospitals. 
Large hospitals will be found to benefit from economies of scale and to operate more 
efficiently.   
This chapter will include a detailed review of the research design chosen to 
develop benchmark statistics, a description of the sampling frame, instrumentation to be 
used, procedures for data collection and data analysis, and any limitations, which should 
be considered when evaluating the study findings. 
Research Method 
Cross-sectional survey methodology will be utilized to collect data for this study.  
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Surveys are commonly used to obtain descriptive statistics of the type that will be 
necessary to establish benchmark statistics for pharmacy departments.  Survey research is 
defined as the use of a systematic method to collect data directly from respondents 
regarding facts, knowledge, attitudes, beliefs, and behaviors of interest to researchers, 
including the analysis of these data using quantitative methods.  Survey research typically 
consists of three characteristics:  chosen sample, systematic instrument, and quantitative 
analysis.  The sample is usually a subset of a larger population of interest.  The data 
collection instrument and procedures are generally standardized for all respondents.    
The results are numerically coded and analyzed quantitatively (Shi, 1997). 
This research project will use a cross-sectional design.  Researchers use cross-
sectional designs as a source of data regarding programs and their environments.  This 
design allows the researcher to portray characteristics of a group at one point in time 
(Fink, 2005, p. 86).  Survey research was chosen as the method to research workload, 
productivity, and staffing metrics in state psychiatric hospitals, because this method has 
been effectively applied in similar settings for similar types of research (Schumock, 
Walton, Sarawate, & Crawford, 2003; Crawford, Schumock, Ursan, Walton, & Donnelly, 
2013; McKee, 1991; Bond & Raehl, 2008; Bond & Raehl, 2007; Raehl & Bond, 2000; 
Pederson, Scheider, & Scheckelhoff, ASHP national survey of pharmacy practice in 
hospital settings: prescribing and transcribing - 2013., 2014; Pederson, Schneider, & 
Scheckelhoff, ASHP national survey of pharmacy practice in hospital settings: dispensing 
and administration - 2014., 2015; Pederson, Schneider, & Scheckelhoff, ASHP national 
survey of pharmacy practice in hospital settings: monitoring and patient education - 
2012., 2013; Casey, Moscovice, & Davidson, 2006; Schumock, Ursan, Crawford, 
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Walton, & Donnelly, 2013; Nau, Garber, Lipowski, & Stevenson, 2004; Gupta, et al., 
Association between hospital size and pharmacy department productivity, 2007; 
Pedersen, Schneider, & Sheckelhoff, ASHP national survey of pharmacy practice in 
hospital settings: Monitoring and patient education - 2015, 2016; Doucette, et al., 2012).   
 In survey research, a self-administered survey is typically distributed either online 
or on paper and the respondents answer the questions based on their knowledge.  Surveys 
are ideal, because many people are familiar with the process of completing a 
questionnaire, it is relatively low cost to distribute questionnaires online, and survey 
results are easily tabulated.  One disadvantage, which will need to be anticipated, is that 
some recipients may not respond to the survey and some will fail to answer all of the 
questions (Fink, 2005, pp. 121-23).  
 Survey instruments may be constructed by the researcher or adapted from 
available instruments used by others.  This study will use a combination of two 
questionnaires, which were previously applied to acute care hospital pharmacies.  The 
advantage to using an instrument used by others is typically that the instrument has 
already been validated and may not need to be pretested prior to use.  The instruments 
that will be used in this study were utilized in previous research, but were not formally 
validated.  This will be a limitation of the study.  Another challenge will be that there will 
likely be additional measures that the researcher would like to incorporate into the 
instrument based on differences in the population of hospitals being studied, but may not, 






Pharmacy directors from across the United States, from member psychiatric 
hospitals of the Minnesota Multistate Contracting Alliance for Pharmacy (MMCAP), will 
serve as the sampling frame for this cross-sectional survey.  MMCAP is a free, voluntary 
group purchasing organization  (GPO) operated by the State of Minnesota for 
government owned entities across the United States.  MMCAP membership is not limited 
to the state of Minnesota.  The sampling frame will include state psychiatric hospitals 
from states all over the United States who are members of MMCAP.  MMCAP is open to 
governmental facilities, which provide healthcare services such as state agencies, 
counties, cities, school districts, correctional, public higher education, and health 
departments (Minnesota Multistate Contracting Alliance for Pharmacy, 2016).   
All hospital directors of pharmacy surveyed will share the similarity of being 
from government owned state psychiatric hospitals.  This is important, since the goal of 
this research is to document benchmarks for pharmacy departments of like type.  The 
resulting data set will provide meaningful metrics for pharmacy directors within state 
psychiatric hospitals to benchmark their departments against. 
There are 195 state psychiatric hospitals in the United States, per the National 
Association of State Mental Health Program Directors website (www.nasmhpd.org).  One 
hundred and fifty-six of the 195 are currently registered by the AHA (American Hospital 
Association, 2016).  One hundred and fifteen of the 156 state psychiatric hospitals are 
currently members of the MMCAP GPO and will be included in this study.  Given the 
number of MMCAP members from state psychiatric hospitals represents 74% of the total 
state psychiatric hospitals registered with the AHA in the United States, the sampling 
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frame will include the entire population of MMCAP members from state psychiatric 
hospitals.  It is assumed that a portion of the 115 will either not respond to the survey or 
will not answer all of the survey questions.  A 50% response rate from this sample of the 
total population of state psychiatric hospitals, who are members of MMCAP, would yield 
57 evaluable questionnaires, which would represent workload and performance 
benchmarks from 37% of all AHA registered, state psychiatric hospitals across the 
United States.  A 100% response rate from this sample would represent 74% of all AHA 
registered, state psychiatric hospitals across the United States. 
To secure collaboration and develop the sampling frame, the MMCAP GPO will 
be contacted to obtain written permission to use member email addresses to send a study 
questionnaire to members.  A list of active member email addresses will be obtained from 
MMCAP.  If MMCAP does not agree to grant permission to use member email addresses 
for the directors of pharmacy, then the survey will be sent to all facility directors as 
posted on the NASMHPD website.  The sampling frame would then change to the entire 
156 AHA registered, state psychiatric hospitals in the nation.  A significant limitation 
will be that the facility directors may ignore the survey request or not forward it to the 
pharmacy director for completion.  The survey response rate may be compromised. 
The list of members in MMCAP will be reviewed to exclude all members except 
those from state psychiatric hospitals from the sampling frame.  This list of hospitals will 
then be compared to the American Hospital Association (AHA) and the NASMHPD 
database to ensure all hospitals to be surveyed are state psychiatric hospitals.   
 Founded in 1989, the American Hospital Association (AHA) is a national 
organization that represents and serves all types of hospitals, health care networks, and 
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their patients and communities. The AHA is made of approximately 5,000 hospitals, 
health care systems, networks, other providers of care and 43,000 individual members. 
The AHA conducts an annual survey of hospitals in the US, collecting data on utilization, 
personnel, revenue, expenses, managed care contracts, community health indicators, 
physician models, etc.  The AHA is considered a definitive source for hospital data and 
will be cross-referenced to verify that hospitals to be surveyed are indeed state 
psychiatric hospitals (American Hospital Association, 2016). 
 Founded in 1959, the National Association of State Mental Health Program 
Directors (NASMHPD) is the only national association representing state mental health 
commissioners/directors and their agencies.  NASMHPD has an affiliation with all 195 
state psychiatric hospitals located throughout the US.  Their list of state psychiatric 
hospital administrators will be cross-referenced to the AHA to verify that hospitals to be 
surveyed are indeed state psychiatric hospitals (National Association of State Mental 
Health Program Directors, 2016). 
Instrumentation 
Questions from a previously validated 50-item questionnaire applied to acute care 
hospitals will be utilized, along with questions from a second, similar 54-item 
questionnaire used to study critical access hospitals (Gupta, et al., 2006; 2007; Crawford, 
Schumock, Ursan, Walton, & Donnelly, 2013).  Some questions in the critical access 
hospital survey are more current, and relevant to today’s practice.  Some questions will 
be eliminated to reduce the length of the survey instrument.  The original survey 
instruments, as well as the combined survey instrument used in this study, can be found 
in Appendix 1, Appendix 2, and Appendix 3. 
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Survey questions will measure the following hospital characteristics:  hospital bed 
size, number of doses dispensed per month, pharmacy expenditures, hours of operation, 
non-distributive pharmacy services provided, distribution and service model, methods for 
measuring workload and productivity, clinical pharmacy services provided, percent of 
time spent in different staffing activities, staffing levels, and number of pharmacy 
interventions.  All questions will be closed-ended questions, which require either 
checking a response box or filling in a number.   
After permission is obtained to utilize the two survey instruments, the 
questionnaires will be combined and converted into an electronic format using the 
REDCap secure web application for building and managing online surveys and databases.  
REDCap allows the researcher to build the survey and distribute it quickly and securely 
(Research Electronic Data Capture).  Some questions from the original survey 
questionnaires will be excluded from the combined survey instrument as necessary, to 
avoid duplicate questions and to focus the instrument on applicability to the study 
population.   
Prior to full distribution of the survey instrument, the questionnaire will be sent to 
six state psychiatric hospital pharmacy directors in the United States for pilot testing.  
Three directors will be from the state psychiatric hospitals in North Carolina, since the 
principle investigator works in North Carolina.  Three other directors will be chosen from 
three other states.  To promote response, the other three directors will likely be directors 
that the principle investigator corresponds with regularly.  The pilot-test will serve as a 
preliminary check to evaluate the survey instrument for clarity and to estimate the time 
required to complete the survey.  The survey instrument will be revised in accordance 
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with their recommendations. 
Data Collection / Procedure 
 There are approximately 115 psychiatric hospital pharmacies within the MMCAP 
GPO. Each hospital will be assigned a unique number to identify responders versus non-
responders.  An email will be sent out to the directors of pharmacy requesting 
participation in the survey, followed by the survey instrument.  See Appendix 4.  
Recipients, at their discretion, will be allowed to ask other staff who may be more 
knowledgeable about specific services or facts to complete the survey for them.  
Recipients will be given 30 days to complete the survey.   
To minimize nonresponse bias, reminder emails will be sent to non-responders 
weekly.  One-week after the deadline for completion, a reminder email will be sent to 
non-responders allowing a two-week extension.  The total survey period should not 
exceed 6 weeks. 
Survey respondents’ facility name will be collected for purposes of determining 
responders versus non-responders and for data clarification.  All names will be kept 
strictly confidential.   
Survey results will be exported from REDCap into the spreadsheet application, 
Microsoft Office Excel, and recoded to facilitate analysis.  Demographic characteristics 
for both respondents and non-respondents will be imputed from the AHA.  These data 
include ownership type, primary service, teaching affiliation, urban versus rural, licensed-
bed size, admissions, outpatient visits, personnel, and total hospital expenses. 
A notice will be send from MMCAP leadership to encourage participation in the 
study.  To further encourage participation in the survey, the investigator will share results 
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of the research with those who complete the survey, by sending the final publication of 
the study results.  
Data Analysis 
Survey results will be analyzed using IBM SPSS Statistics, Version 24. 
Descriptive statistics will be used to profile the responses and characterize the sample.  
Demographic characteristics from the AHA will be used, including the ownership type, 
primary service, teaching affiliation, urban versus rural, licensed-bed size, admissions, 
out-patient visits, personnel, and total hospital expenses.  Similar to comparable research, 
demographic characteristics will be compared for survey responders versus non-
responders to determine if statistically significant differences are found (Gupta, et al., 
Monitoring of pharmacy staffing, workload, and productivity in community hospitals, 
2006, pp. 1729-1730).  Standard Student’s t tests will be used to determine whether 
demographic characteristics and frequency distributions differ between respondents and 
non-respondents and respondents versus other state psychiatric hospitals. The a priori 
level of significance will be set at 0.05.   
Data collected from the survey instrument will be blinded and organized by 
number of occupied beds.  It will be determined how best to group the hospital data, 
based upon the responses received.  For each survey question answerable with a 
continuous variable (e.g., the number of pharmacists employed), the mean plus or minus 
the standard deviation (S.D.) and median of the entire sample will be reported, as well as 
the maximum and minimum values reported. Staffing, workload, and productivity 
variables to be reported include:   
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• Total pharmacy expenditures per 100 occupied beds and per 1000 patient 
days 
• Pharmaceutical expenditures per 100 occupied beds and per 1000 patient 
days 
• Pharmacy personnel expenditures per 100 occupied beds and per 1000 
patient days 
• Doses dispensed, billed, or administered per month per 100 occupied beds 
and per 1000 patient days 
• Orders per month per 100 occupied beds and per 1000 patient days 
• FTEs per 1000 doses dispensed/administered 
• FTEs per 1000 orders processed per month 
• FTEs per 1000 patient days 
• FTEs per 1000 admissions 
• FTEs per 100 occupied beds 
• Pharmacist FTEs per 100 occupied beds and 1000 patient days 
• Technician FTEs per 100 occupied beds and 1000 patient days 
• Productive hours paid per week per FTE 
• Clinical interventions per month per 100 occupied beds and 1000 patient 
days 
• Clinical interventions per month per Pharmacist FTE 
Response rate will be evaluated, with a goal of 50% (Shi, 1997, p. 170).  Missing 





The author has no assumptions to report.   
Limitations  
The purpose of this study is to define benchmarks in state owned psychiatric 
hospitals; therefore, data is specific to state psychiatric hospital departments of pharmacy 
and should not be applied to other types of pharmacy departments. 
The sampling frame represents only active members of the MMCAP GPO.  There 
may be differences between the 41 state psychiatric hospitals, which are not currently 
members of the MMCAP GPO. 
This survey will be quantitative in nature and not qualitative; therefore, data 
demonstrating that respondents have a given service in place says nothing about that 
particular service’s ability to improve the quality of care or its impact on patient 
outcomes (McKee, 1991, p. 973). 
The instruments that will be used in this study were utilized in previous research, 
but were not formally validated.   The psychometric properties of the instrument have not 
been defined.  The instrument has not been assessed for validity and reliability.  This will 
be a limitation of the study.   
As reported in similar studies, there will be a potential for responder bias, non-
responder bias, and misclassification bias (Gupta, et al., Association between hospital 
size and pharmacy department productivity, 2007, p. 944; McKee, 1991, p. 973).  To 
minimize non-responder bias, an incentive will be offered to encourage response, 
including receipt of published data upon completion of the study. Also, reminder emails 
will be sent weekly to non-responders to encourage participation.  A final email will be 
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sent to non-responders to request participation one-week after the completion deadline, 
along with a deadline extension.   
There may be a difference between survey responders and non-responders, which 
could introduce bias.  To minimize non-responder bias, efforts will be made to 
characterize the non-responder group compared to the responder group to determine 
possible differences based on geographic location or bedsize.  The sampling frame 
(responders plus non-responders) will also be compared to the total 156 hospitals to 
determine similarity based on geographic location and bed size.  The average bedsize of 
MMCAP member psychiatric hospitals nationwide and the total 156 hospitals will be 
determined and compared to the average bedsize of responders. If the average bedsize is 
similar, then the sample will be assumed to represent the larger population.  Likewise, the 
geographic location and distribution of responders will be compared to the overall 
population of MMCAP member state psychiatric hospitals.  If these characteristics match 
the overall characteristics of the larger population, then the bias may be minimized or 
eliminated.  No efforts will be made to ensure the accuracy of the responses to the survey. 
It should be anticipated that by grouping hospital data by occupied bed size, the 
number of respondents in each category could be too small to detect a difference amongst 
the groups.  If respondents do not answer all questions, then certain measures may have 
limited responses, which define the characteristic for the group.  Such limitations will 
limit the representativeness of the sample and the power of the analysis (Gupta, et al., 
Association between hospital size and pharmacy department productivity, 2007, p. 944). 
It will not be within the scope of this study to evaluate all parameters within 
pharmacy operations, which are presumed to have an impact on productivity.  Further 
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research is warranted, perhaps via multivariate analysis, to evaluate the impact of 
technology on productivity.  If a multivariate analysis were to be completed, variables 
such as utilization of computerized physician order entry, electronic health records, 
automated dispensing cabinets, smart infusion pumps, dispensing robotics, and barcode 
use upon administration should be collected. 
Finally, there may be interactions between hospital size, geographic location, and 
hospital mission, which would affect survey responses (McKee, 1991, p. 973).  These 
factors will be beyond the scope of this study. 
Protection of Human Subjects 
 Institutional Review Board (IRB) approval is required for all research at the 
Medical University of South Carolina (MUSC), including survey research.  After 
consulting with the Committee Chair, the PI followed all IRB procedures to complete and 
submit the project for IRB review through the eIRB portal as exempt, non-human 
research.  The original submission was posted on September 1, 2016. 
 As of October 22, 2016, the IRB had not yet approved the study as exempt, non-
human research.  An explanation of why this research should be considered exempt, non-
human research was provided on October 13, 2016, via a response to the notification 
email and through the eIRB portal.  Copies of the two survey instruments, which will be 
used to prepare the survey to be used in this study, were appended to the eIRB portal on 
October 13, 2016. 
 Per the IRBs request, the survey instrument was modified to remove the 
pharmacist name from the survey instrument and resubmitted for consideration on 
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November 8, 2016.  The study was approved as non-human subject research on 
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Purpose:  To establish benchmarks for assessing workload, staffing, and productivity in 
state psychiatric hospital pharmacy departments, and to compare productivity by bed 
size.   
Methods:  An electronic survey of state psychiatric hospitals was conducted.  Hospitals 
were categorized based on number of occupied beds.  Descriptive statistics using 
Student’s t-tests, Pearson Chi-Square, and Pearson Correlations were used to characterize 
the data and compare productivity by bed size. 
Results: Responses were received from 41 hospitals (35.7%) and benchmarks were 
established.  Respondent hospitals did not differ from non-respondents based on 
demographic data from the American Hospital Association (AHA) DataViewer. There 
was a positive correlation between daily census, patient days, expenditures, paid hours 
and productive hours per week, workload metrics, total pharmacy staff, and occupied bed 
size (r=0.381-0.991, p<0.05).  Over 30% of hospitals reported using no indicators to 
monitor pharmacy productivity. Productivity ratios differed between Very Small/Small 
and Medium/Large hospital groups:  mean pharmaceutical expenditures per 100 occupied 
beds and per 1000 patient days (p=0.017 and 0.05 respectively), mean FTEs per 1000 
doses dispensed/administered per month and per 100 occupied beds (p=0.042 and 0.026), 
and mean pharmacist and technician FTEs per 100 occupied beds  (p=0.012 and 0.019 
respectively).  
Conclusion:  Results of the survey suggest staffing, workload, and productivity metrics 
to be dependent on bed size, with larger hospitals operating more efficiently than 
	
hospitals of lower bed size. Over 30% of hospitals reported using no indicators to 
monitor pharmacy productivity. 






















The public mental health service delivery system serves 7.3 million people each 
year, under a $41 billion budget.1,2  State resources for mental healthcare services are 
limited, requiring state hospitals to operate as efficiently as possible.  As a result, 
pharmacy departments in these facilities are under pressure to ensure optimal 
productivity.3 
Benchmarking productivity and workload measurement against other facilities 
can facilitate operating an efficient hospital pharmacy; however, sources for current 
external metrics and benchmarks for pharmacy staffing, workload, and productivity in 
psychiatric hospitals do not exist.  The American Society of Health System Pharmacists 
(ASHP) conducts a national survey to describe pharmaceutical services in acute care 
hospitals, and publishes pharmacy metrics on prescribing, transcribing, dispensing, 
administration, monitoring, and patient education; however, these data are specific to 
acute care hospitals. Other types of hospitals are excluded from the ASHP surveys, 
including psychiatric hospitals. 4,5,6   
Therefore, the purpose of this study was to describe current benchmark statistics 
on workload, staffing, and productivity in hospital pharmacy departments of state 
psychiatric hospitals and to compare these data by hospital size. It was hypothesized that 
hospital volume, pharmacy expenditures, hours of operation, full-time equivalents 
(FTEs), and dispensing workload would vary based on the size of the facility.  Moreover, 
for such data to be useful for benchmarking, psychiatric hospitals would need the data 
stratified by hospital size. 
Methods 
We conducted a cross-sectional survey of psychiatric hospital pharmacy 
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departments, which were members of Minnesota Multistate Contracting Alliance for 
Pharmacy (MMCAP), a group purchasing organization (GPO) operated by the State of 
Minnesota for government owned entities across the United States (US).7  At the time of 
the survey, there were 195 state psychiatric hospitals in the United States, of which 115 
were members of the MMCAP GPO.  All 115 psychiatric hospitals were included in the 
survey - representing 74% of the total state psychiatric hospitals, which were registered 
with the American Hospital Association (AHA) and the National Association of State 
Mental Health Program Directors (NASMHPD)1 at the time of the survey. 
A draft questionnaire was developed using items from two questionnaires, which 
were used in previously published surveys of pharmacy productivity in acute care 
hospitals.8,9,10 Survey questions measured hospital bed size, number of doses dispensed 
per month, pharmacy expenditures, hours of operation, non-distributive pharmacy 
services provided, distribution and service model, methods for measuring workload and 
productivity, clinical pharmacy services provided, percent of time spent in different 
staffing activities, staffing levels, and number of pharmacy interventions. The draft 
version of the questionnaire was pre-tested by six pharmacy directors from the target 
population.  Questions were modified based on suggestions from the pilot test.  The final 
30-item questionnaire was prepared in an electronic format using REDCap (Research 
Electronic Data Capture).   
Each of 115 state psychiatric hospitals was assigned a unique number to track 
responses.  In December of 2016, an email was sent to the director of pharmacy at each 
facility requesting participation in the survey, with a link to the electronic questionnaire.  
The director of pharmacy was encouraged to seek input from others in the department to 
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complete the questionnaire within 30 days.  To minimize nonresponse bias, reminder 
emails were sent to non-responders weekly.  One-week after the deadline for completion, 
a reminder email was sent to non-responders allowing a two-week extension.   
Responses were exported from REDCap into the spreadsheet application, 
Microsoft Office Excel, and recoded to facilitate analysis.  No efforts were made to verify 
the accuracy of the responses.  Demographic characteristics for both respondents and 
non-respondents were imputed from AHA DataViewer.11  These data included licensed-
bed size, admissions, outpatient visits, total hospital expenses, personnel (number of 
FTEs), and urban versus rural location. 
Data were analyzed using IBM SPSS Statistics, Version 24. Descriptive statistics 
were used to profile respondents and characterize the responses. Standard Student’s 
independent, two-tailed t-tests and Pearson Chi-Square were used to determine whether 
demographic characteristics differed between respondents and non-respondents. Data 
were organized by number of occupied beds for each responding facility. Bed groups 
were defined as Very Small (<100 beds), Small (100 to 180 beds), Medium (181 to 299), 
and Large (300 to 650 beds) to facilitate benchmarking.  Pearson correlations were used 
to determine the relationship between observed characteristics and occupied bed size.  
The Very Small and Small bed groupings and the Medium and Large bed groupings were 
collapsed for statistical comparison using Standard Student’s independent, two-tailed t-
tests.  Missing values on the survey were excluded from analyses.  The a priori level of 
significance was set at 0.05.   
Institutional Review Board of the Medical University of South Carolina approved 
the study as non-human subject research, on November 10, 2016.  Survey respondents’ 
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facility names were collected for purposes of linking AHA, MMCAP, and NASMHPD 
lists.  All respondents’ names were kept strictly confidential.   
Results 
Responses were received from 41 out of 115 hospitals, for a response rate of 
35.7%. Table 1 shows the number of licensed beds, admissions, outpatient visits, total 
hospital expenses, number of FTEs, and urban versus rural hospital locations from the 
AHA DataViewer for respondents, non-respondents, and the overall population of state 
psychiatric hospitals.  Table 1 also displays geographic and bed size similarities between 
the groups.  No significant differences were found between respondents and non-
respondents, or between respondents and state psychiatric hospitals.  
Table 2 provides pharmacy benchmark data as reported by respondent hospitals, 
grouped by occupied bed size. Average inpatient census, patient days per year, 
expenditures, and workload were found to correlate positively to occupied bed size 
(r=0.643-0.991, p<0.05).  For example, pharmacy expenditures for Large hospitals were 
4.3 times more than Very Small hospitals, 2.1 times larger than Small hospitals, and 1.4 
times more than Medium hospitals.  Doses dispensed or administered per month were 10 
times higher for Large hospitals than Very Small hospitals, 4.5 times more than Small 
hospitals, and 1.4 times more than Medium hospitals.  
Respondents reported various indicators used to monitor hospital productivity, as 
displayed in Table 3.  Of the respondent hospitals, 31.7% reported not using any 
indicators to monitor productivity.  The most common indicators reported were doses 
dispensed per month (22.0%), FTEs per doses dispensed (14.6%), FTEs per patient day 
(12.2%), and FTEs per order processed (9.8%).  Some hospitals (7.3%) reported using 
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other productivity indicators, including doses dispensed per hours of pharmacy operation, 
number of automated dispensing cabinet refills per 1000 patient days, number of doses 
dispensed per 1000 patient days, new orders per 1000 patient days, and new orders per 
hours of pharmacy operation.  
Measures of pharmacy department effectiveness used by respondent hospitals are 
shown in Table 4.  The most common measures reported included results from regulatory 
assessments such as The Joint Commission and Boards of Pharmacy (63.4%), 
pharmaceutical expenditures (51.2%), number of medication errors (51.2%), and number 
or type of clinical interventions (46.3%). 
Respondents were asked to report the number of FTEs for various positions in the 
pharmacy department, as shown in Table 5. There was a positive correlation between 
occupied bed size and the number of supervisor/manager, dispensing/staff pharmacist, 
pharmacy technician, other non-pharmacist staff, and total pharmacy FTEs (r=0.381-
0.537, p<0.05). The mean number of total pharmacy staff FTEs (pharmacist, pharmacy 
technicians, and other) for each of four groups based on bed size was 4.3, 7.3, 10.5, and 
14.5 FTEs respectively, for Very Small, Small, Medium, and Large hospitals. The mean 
number of dispensing/staff pharmacist FTEs for each of four bed groups based on bed 
size was 0.9, 1.0, 1.1, and 2.7, respectively. The mean number of pharmacy technician 
FTEs for each of four groups based on bed size was 1.8, 2.8, 4.2, and 6.0, respectively.   
Respondents reported the number of productive and paid hours per week for the 
pharmacy department.  A positive correlation was found between occupied bed size and 
productive hours per week (r=0.633, p=0.000) and paid hours per week (r=0.563, 
p=0.001).  The range of productive and paid hours per week ranged from 112.5 to 800 
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hours and 112.50 to 1400 hours, respectively. Large hospitals had approximately 2.9 to 
3.5 times more productive and paid hours per week than Very Small hospitals 
respectively, 2.0 to 2.3 times more than Small hospitals, and 1.3 to 1.4 times more than 
Medium hospitals respectively. 
The percentage of staff time in each of four categories (drug dispensing, clinical, 
management, and other) was reported. More time was spent in drug dispensing for Large 
hospitals and more time for management activities was spent in Very Small hospitals.  
Means ranged from 50.0 to 57.8% of time spent on drug dispensing, 26.5 to 31.1% of 
time spent on clinical services, 11.2 to 16.1% of time spent on management, and 1.3 to 
5.5% on other duties.  
Data was collected on workload metrics of doses dispensed or administered per 
month and orders per month for each hospital.  As expected, there was a strong positive 
correlation between doses dispensed or administered per month and occupied bed size 
(r=0.643, p=0.000).  Large hospitals had 10.0 times as many doses per month as Very 
Small hospitals, 4.5 times as many as Small hospitals, and 1.4 times as many as Medium 
hospitals.  Orders per month demonstrated a similar trend (r=0.643, p=0.000).  Large 
hospitals had almost 12.0 times as many orders per month as Very Small hospitals, 3.4 
times as many as Small hospitals, and 2.9 times as many as Medium hospitals.  
Respondents were asked to report the percent of applicable patients for which 
various patient-specific clinical services were provided.  All services provided in at least 
50.0 to 100% of eligible patients are displayed in Table 6, categorized by occupied bed 
size.  The top 5 most commonly provided services were drug therapy monitoring, 
anticoagulation monitoring, medication reconciliation, renal dosing, and antibiotic 
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dosing/monitoring.  Other clinical services reported by respondents included attending 
treatment team meetings, movement disorder assessments, quarterly drug regimen 
reviews for patients with greater than 90-day length of stay, multiple antipsychotic 
review/tracking, fall risk assessments, group facilitation in treatment malls, prospective 
medication therapy management for high risk medications, clozapine monitoring, 
hazardous medication management, and drug management consultations. 
Finally, respondents were asked to report on non-distributive services provided by 
the pharmacy, as shown in Table 6. The most commonly provided non-distributive 
services were medication error monitoring/reporting, adverse drug reaction 
monitoring/reporting, drug information service, protocol development and/or 
management, and educational inservices.  Other non-distributive services, noted by 
respondents were benefit investigation, prior authorization requests, patient education 
groups, participation in root cause analysis workgroups, and data collection for infection 
control and nutritional services. 
Based on data provided by survey respondents, a series of productivity and 
workload ratios were calculated with the goal of comparing productivity by occupied bed 
size. Means and standard deviations of the Very Small, Small, Medium, and Large 
hospital groups are provided for benchmarking purposes in Table 7.  For example, as 
shown in Table 7 that Large hospitals staffed their pharmacy departments with a mean of 
1.8 pharmacist FTEs per 100 occupied beds, compared to 2.3, 3.1, and 3.6 in Medium, 
Small, and Very Small hospitals respectively. 
Due to the small sample sizes in the Very Small, Small, Medium, and Large 
hospital groups, the authors did not expect there to be sufficient statistical power for 
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comparison of productivity and workload ratios between the four groups; therefore, 
means of the combined Very Small/Small and Medium/Large hospitals were compared 
for all productivity ratios. Differences were found between Very Small/Small and 
Medium/Large hospitals, with regards to staffing resources per doses dispensed or 
administered and occupied bed size.  The mean FTEs per 1000 doses dispensed or 
administered per month was 0.6 and 0.1 FTEs per 1000 doses dispensed or administered 
per month for Very Small/Small and Medium/Large hospitals respectively (p=0.042).  
Similarly, the mean FTEs per 100 occupied beds per month were different with 5.9 and 4 
FTEs per 100 occupied beds for Very Small/Small and Medium/Large hospitals 
respectively (p=0.026).  The mean pharmacist FTEs per 100 occupied beds was 3.3 in 
Very Small/Small hospitals and 2 in Medium/Large hospitals (p=0.012).  The mean 
pharmacy technician FTEs per 100 occupied beds was 2.8 in Very Small/Small hospitals 
and 1.8 in Medium/Large hospitals (p=0.019).   
Expenditure ratios were calculated based on the data provided by survey 
respondents and compared based on occupied bed size for Very Small/Small and 
Medium/Large hospitals.  The mean pharmaceutical expenditures per 100 occupied beds 
was $1,002,350 and $647,115 for Very Small/Small and Medium/Large hospitals 
respectively (p=0.017).  The mean pharmaceutical expenditures per 1000 patient days 
was $34,339 and $19,765 for Very Small/Small and Medium/Large hospitals respectively 
(p=0.05).  Although expenditure ratios tended to be highest for Very Small and Small 
hospitals, ratios comparing total pharmacy expenditures and pharmacy personnel 
expenditures per 100 occupied beds and 1000 patient days for Very Small/Small and 




Pharmacy leaders continue to be challenged with cutting labor costs.  Pharmacy 
managers must be able to understand their workload and productivity metrics, being able 
to both articulate and provide evidence of the value their departments provide, while 
being able to make wise decisions to make effective and efficient changes within their 
departments.12,13   
Prior to this study, state psychiatric hospital pharmacy department leaders were 
limited to general medical-surgical hospital data for comparison, which was arguably not 
a similar peer group.  Services provided in a general medical-surgical hospital are very 
different than those of a specialized state psychiatric hospital.  Directors of pharmacy in 
state psychiatric hospitals should use the data provided through this research to 
benchmark their own productivity metrics.  Use of these new benchmarks will allow 
pharmacy administrators to identify potential opportunities to improve staffing 
efficiencies, pharmacy services, and financial performance, with the overall goal of 
improving value in their organizations.  
As expected, we found hospital volume statistics, FTEs, and dispensing workload 
were associated with bed size of the facility.  The larger the hospital, the more occupied 
beds, the higher the inpatient daily census, more patient days per year, pharmacy 
expenditures, pharmaceutical expenditures, personnel expenditures, doses 
dispensed/administered, and orders per month.  Measures, which were found to be 
independent of bed size included:  pharmacist practice model, forensic populations, hours 
of operation, productive hours paid, and allocation of staff time.  
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We also found that productivity and workload ratios were higher in smaller 
hospitals compared to larger hospitals.  This was expected, as hospitals of larger size 
typically realize economies of scale as bed size increases, while small hospitals must staff 
to a minimum level of service and safety. 
There continues to be a need to examine and improve how pharmacy department 
resources are deployed to address the needs of patients in state psychiatric hospitals. 
Clinical pharmacy services have been found to offer benefits in excess of costs; however, 
due to relatively high salaries and perhaps the history of the state psychiatric hospital, 
pharmacy personnel continue to be the object of staffing reductions.14  When comparing 
staffing metrics to data reported by McKee in 1991, there has been an increase in the 
mean number of pharmacist and technician FTEs staffed in the state psychiatric hospitals.  
The mean pharmacist FTEs per respondent hospital has increased by 1.2 FTEs (3.5±0.7 
in 1989 compared to 4.7±3.3 in 2016).  This staffing metric still tends to vary by bed size 
of the hospital, with the mean number of pharmacist FTEs reported as being 4.1±9.6 
FTEs per 100 licensed beds in 2016 compared to 1.6±0.3 per 100 licensed beds in 1989.  
Likewise, the mean number of technician FTEs per respondent hospital has nearly 
doubled from 2.4±0.6 FTEs in 1989 to 4.2±3.1 in 2016.  The mean number of technicians 
per 100 licensed beds was 1.3±0.3, compared to 3.6±8.1 technician FTEs per 100 
licensed beds in 2016.15  Of note, these comparisons were made using the number of 
licensed beds, because the McKee study measured the number of licensed beds rather 
than occupied beds.  In this current study, the number of occupied beds reported was 
higher than the number of licensed beds (mean of 216.2 occupied beds reported versus a 
mean of 205.3 licensed beds per AHA DataViewer). 
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The type of pharmacy practice model deployed in state psychiatric hospitals, 
particularly the integrated pharmacy practice model, is considered to be an indicator of 
quality.  Having a practice model, which ensures capable, competent pharmacists are 
available at all times is consistent with the Institute Of Medicine’s (IOM’s) call for high-
quality, patient-centered care.16 In this study, 68% of respondents reported having a 
patient-centered or integrated pharmacy practice model.  This staffing model was most 
prevalent across each of the four bed groups, with respondents reporting a mean of 29, 
29.9, 31.1, and 26.5% of staff time spent in clinical pharmacy activities for Very Small, 
Small, Medium, and Large hospitals respectively.  This is in contrast to 1990, when it 
was reported that to spite the documented benefits of clinical pharmacy services, some 
organizations had not yet chosen to support expanded pharmacy functions, beyond 
traditional dispensing roles.17 
Hospitals reported employing an average of 0.4 clinical pharmacist FTEs per 
hospital, with 26.8% of hospitals reporting having at least 0.2 clinical pharmacist FTEs 
on staff.  This is an improvement from 22% in the late 1980s.15  An even larger 
percentage of hospitals (34.1%) reported having at least one integrated pharmacist FTE 
on staff, performing both clinical and distributive functions.  Only one hospital reported 
having no pharmacy technicians, compared to the many smaller hospitals having no 
pharmacy technicians in the 1980s.15    
Similar to findings of other researchers8, total pharmacy costs and pharmaceutical 
expenditures generally decreased as hospital size increased, reflecting economies of scale 
with regards to personnel and total costs, which occur when the volume of work and 
patient population increase.  As the size of the hospital increases, pharmacy departments 
	120	
	
become more efficient.  This was evident in the expenditure ratios applied to Very 
Small/Small and Medium/Large hospital groups.  In general, expenditure ratios decreased 
as hospital size increased.   
The difference between the small and large hospitals was significant with regards 
to mean pharmaceutical expenditures, both statistically and clinically, with small 
hospitals spending $1,002,350 on pharmaceutical expenditures per 100 occupied beds 
and large hospitals spending $647,115 per 100 occupied beds.  There are many factors 
that may have attributed to this difference in cost along with economies of scale, 
including differences in the types and acuity of patients served in the facility, ability to 
discharge patients into the community in a timely manner, percentage of forensic 
population, number of pharmacist FTEs,  clinical service model, formulary structure, 
including the use of expensive long-acting injectable antipsychotics, and patient length of 
stay.  The impact of these variables on pharmaceutical expenditures warrants further 
study. 
It should be noted that due to small sample sizes in each category of occupied bed 
size, outliers were not excluded from the data.  The presence of outliers may have 
impacted the overall representative metric in these categories.  For example, pharmacy 
personnel expenditures per 100 occupied beds trended down, the larger the hospital; 
however, the medium size hospitals did not follow this trend.  This was likely due to two 
of the hospitals in this category having twice the pharmacy personnel compared to the 
mean of the medium hospital category.  
There are several limitations, which should be considered when interpreting our 
results. First, the purpose of this study was to define benchmarks in state owned 
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psychiatric hospitals; therefore, data was specific to state psychiatric hospital departments 
of pharmacy and should not be applied to other types of pharmacy departments.  It should 
be noted that external benchmarks should serve as roadmaps or general guidelines for 
comparison, but not absolute determinants of how an individual hospital should 
perform.18 
Second, the response rate of 35.7% is consistent with similar pharmacy survey 
research; however, per Baruch and Holtom (2009), any level of non-response can (but 
need not) induce non-response bias in survey estimates.  The authors explain, “Clarity 
about what rate of non-response should be considered ‘too high’ is elusive.”19 It should 
be noted that a recent study published by Hardigan et al. (2016) evaluated response rates 
of practicing pharmacists and reported survey researchers have experienced declining 
response rates in recent years.  Hardigan acknowledged biased results threaten validity, 
yet analysts must cope with the reality of declining response rates.  In Hardigan’s study, 
response rates from questionnaires administered to practicing pharmacists averaged 
23.3%.  He cited a 2006 response rate to an analogous questionnaire of 25.5%.20  
Response rates reported in recent American Society of Health System Pharmacists 
(ASHP) national surveys were 28.9% in 2013, 29.7% in 2014, and 22.7% in 2015.4,5,6   
Response representativeness is more important than response rate in survey 
research.19  The responders and non-responders in this study did not differ significantly 
with regards to licensed beds (p=0.184), admissions (p=0.2), outpatient visits (p=0.179), 
total expenses (p=0.991), and personnel (0.869) as defined by AHA DataViewer. 
Regardless, there may have been differences between the 41 state psychiatric hospitals, 
which were not fully realized. 
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Third, grouping data by occupied bed size was necessary to allow the data to be 
used for its intended purpose, as a benchmarking tool for other state psychiatric hospitals 
of various bed sizes.  As noted in similar research8, grouping hospital data by occupied 
bed size, may result in the number of respondents in each category being too small to 
detect a difference amongst the groups.  Furthermore, when all questions are not 
answered, certain measures have limited responses, which subsequently defines the 
characteristic for the group.  Such limitations may have reduced the representativeness of 
the sample and the power of the analysis.   
Considering the small samples within the Very Small, Small, Medium, and Large 
hospital groups, only the combined groups of Very Small/Small and Medium/Large 
hospitals were used to evaluate statistically significant differences in the cost efficiency 
and productivity ratios.  Even the combined groups may have lacked sufficient numbers 
of respondents to detect a difference when a difference did indeed exist. 
Fourth, this survey was quantitative in nature and not qualitative; therefore, as 
noted in similar research,15 data demonstrating respondents had a given service in place 
did not demonstrate the particular service’s ability to improve the quality of care or its 
impact on patient outcomes. 
Fifth, the instruments utilized in this study were used in previous research; 
however, they were not formally validated.  The psychometric properties of the 
instrument have not been defined, nor has it been assessed for validity and reliability.  
Finally, it was not within the scope of this study to evaluate all parameters within 
pharmacy and overall hospital operations, which are presumed to have an impact on 
productivity.  Further research is warranted, perhaps via multivariate analysis, to evaluate 
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the impact of patient acuity, availability of behavioral health resources in the community, 
percentage of forensic population served, and technology on productivity.  If a 
multivariate analysis were to be completed, variables such as utilization of computerized 
physician order entry, electronic health records, automated dispensing cabinets, smart 
infusion pumps, dispensing robotics, and barcode use upon administration should also be 
studied. 
Conclusion 
The objective of this quality improvement study was to develop current 
benchmarks for use in assessing workload, staffing, and productivity metrics used in 
hospital pharmacy departments of state psychiatric hospitals.  Use of these new 
benchmarks will allow pharmacy administrators to identify opportunities for improving 
workforce efficiency, pharmaceutical care services, and financial performance, with the 















Demographic characteristics of respondent, nonrespondent, and all state psychiatric hospitalsa 
aData for this table were obtained from the American Hospital Association (AHA) DataViewer. 
bFTE= full-time equivalent 
cNo statistically significant differences were found between respondents and nonrespondents, or between 






























(n=  75) 
State Psychiatric 
Hospitals  
(MMCAP members + 
others) 
(n=156) 
Licensed bedsc 205 ± 139 230 ± 189 242 ± 213 
Admissionsc 1074 ± 106 1163 ± 1495 1079 ± 1276 
Outpatient visitsc 4327 ± 11764 7434 ± 16410 6207 ± 14556 




$57,311,593 ±  
$45,407,365 
Personnel (number of 
FTEs)b,c 
599 ± 416 565 ± 399 600 ± 435 
Urban (%)c 68.3 78.7 76.3 
Region                                                 Mean Licensed beds (%) 
Northeast 72 ± 29 (5) 258 ± 208 (33) 247 ± 192 (25) 
MidWest 175 ± 143 (27) 187 ± 90 (20) 178 ± 100 (26) 
South 222 ± 132 (56) 239 ± 218 (39) 228 ± 183 (37) 
West 250 ± 175 (12) 181 ± 139 (8) 408 ± 381 (12) 
Size 
<100 beds 55 ± 30 (22) 56 ± 17 (24) 55 ± 22 (22) 
100-180 beds 130 ± 20 (24) 143 ± 27 (25) 138 ± 26 (26) 
181-299 beds 240 ± 43 (37) 235 ± 37 (28) 238 ± 38 (30) 
300-650 432 ± 129 (17) 434 ± 107 (19) 434 ± 104 (17) 





Demographic characteristics of respondent hospitals grouped by occupied bedsize  
Characteristics Number of Occupied Beds 













Occupied beds 69 ± 23 (10) 137 ± 29 (10) 238 ± 45 (10) 421 ± 122 (10) 
Admissions 1688 ± 3303 (6) 716 ± 898 (9) 1105 ± 1343 (8) 1422 ± 1038 (9) 
Length of stay 293 ± 595 (8) 415 ± 688 (8) 149 ± 118 (8) 522 ± 753 (10) 
Average inpatient 
daily censusa 
61 ± 22 (9) 134 ± 28 (10) 215 ± 35 (10) 383 ± 105 (10) 
Patient days per 
yeara 
14,209  
± 10,089 (7) 
41,864  
± 16,429 (7) 
77,548  
± 16,298 (5) 
141,780  
± 45,368 (7) 
% Forensic 
patients 




± $159,473 (4) 
$1,823,318 
± $781,004 (8) 
$2,791,501 
± $499,248 (6) 
$3,898,073 




± $324,897 (5) 
$1,485,263 
± $707,652 (8) 
$1,551,479 
± $421,605 (8) 
$2,616,536 





± $114,684 (4) 
$511,322 
± $203,723 (8) 
$1,081,745 
± $613,179 (6) 
$1,233,939 
± $908,191 (10) 
Weekly inpatient 
pharmacy hours 





± 4,594 (5) 
 
33,840  
± 25,294 (8) 
 
107,919  
± 49,005 (8) 
 
153,200  
± 73,163 (8) 
 
Orders per montha 929  
± 788 (5) 
3,191  
± 1,962 (8) 
3,851  
± 2,555 (7) 
10,983  





± 142 (5) 
30 
 ± 14 (10) 
31  
± 17 (8) 
122  
± 85 (10) 


















Indicators used to monitor hospital pharmacy productivity (n= 41)a 
 
Ratio No. (%)b 
None 13 (31.7) 
Doses dispensed per month 9 (22.0) 
FTEs per doses dispensed 6 (14.6) 
FTEs per patient day 5 (12.2) 
FTEs per orders processed 4 (9.8) 
FTEs per relative work unit (or similar weighted measure) 3 (7.3) 
Others 3 (7.3) 
FTEs per occupied bed 2 (4.9) 
FTEs per doses administered 1 (2.4) 
Doses administered per month 1 (2.4) 
FTE per doses billed 0 
FTEs per adjusted patient day (adjusted for outpatient visits) 0 
FTEs per pharmacy department adjusted patient day (adjusted by pharmacy revenue) 0 
FTEs per case mix index (or case mix index adjusted patient day) 0 
FTEs per admission 0 
aFTE = full-time equivalent 





Measures used to describe pharmacy department effectiveness (n=33)a 
 
Measure or Indicator No. (%)b 
Regulatory assessment results (BOH, BOP, TJC, HFAP, etc.)  26 (63.4) 
Pharmaceutical expenditures 21 (51.2) 
Number of medication errors   21 (51.2) 
Number or type of clinical interventions 19 (46.3) 
Nursing satisfaction with pharmacy services   15 (35.6) 
Total pharmacy expenditures  13 (31.7) 
Number of adverse drug reactions 13 (31.7) 
Physician satisfaction with pharmacy services   13 (31.7) 
Percentage acceptance of interventions 8 (19.5) 
Turn-around time   6 (14.6) 
Number of automated dispensing unit discrepancies  5 (12.2) 
Average length of stay   3 (7.3) 
Patient mortality rate   1 (2.4) 
Quality as determined by some type of peer review  1 (2.4) 
Patient satisfaction with pharmacy services   1 (2.4) 
None 1 (2.4) 
Average length of stay by DRG 0 
Others 0 
aBOH = Board of Health, BOP = Board of Pharmacy, TJC = The Joint Commission, HFAP = Healthcare 
Facilities Accreditation Program, DRG = diagnosis related group 







Full-time equivalents by position, among hospitals group by occupied bed sizea 
 
Position Title Full Time Equivalents 













Director 0.8 ± 0.4 (9) 1.0 ± 0.2 (10) 1 ± 0 (9) 1 ± 0 (10) 
Associate/Assistant 
Director 
0 ± 0 (9) 0.1 ± 0.3 (10) 0.4 ± 0.5 (9) 0.3 ± 0.5 (10) 
Supervisor/Managerb 0.1 ± 0.3 (9) 0.1 ± .3 (10) 0.1 ± 0.3 (9) 0.3 ± 0.7 (10) 
Clinical 
Coordinator/Manager 
0.2 ± 0.4 (9) 0.1 ± 0.3 (10) 0 ± 0 (9) 0 ± 0 (10) 
Clinical Pharmacist 0.1 ± 0.3 (9) 0.2 ± 0.7 (9) 0.4 ± 0.7 (9) 0.7 ± 0.9 (10) 
Dispensing/Staff 
Pharmacistb 




0.1 ± 0.3 (9) 1 ± 1.3 (10) 2.1 ± 3.5 (9) 1.9 ± 4.0 (10) 
Informatics 
Pharmacist 
0 ± 0 (9) 0 ± 0 (10) 0 ± 0 (9) 0.2 ± 0.6 (10) 
Medication Use/Safety 
Pharmacist 
0 ± 0 (9) 0.1 ± 0.3 (10) 0 ± 0 (9) 0 ± 0 (10) 
Other Pharmacists 0 ± 0 (9) 0.1 ± 0.3 (10) 0.1 ± 0.3 (9) 0 ± 0 (10) 
Pharmacy Resident  0.1 ± 0.3 (9) 0.2 ± 0.4 (10) 0 ± 0 (9) 0 ± 0 (10) 
Pharmacy Technician 
Buyer 
0.2 ± 0.4 (9) 0.5 ± 0.8 (8) 0.3 ± 0.5 (9) 0.5 ± 0.5 (10) 




0 ± 0 (9) 0.2 ± 0.4 (9) 0.6 ± 0.5 (9) 0.5 ± 0.5 (10) 
Other Non-Pharmacist 
Staff b 
0 ± 0 (9) 0.1 ± 0.3 (9) 0.1 ± 0.3 (9) 0.5 ± 0.5 (10) 
Total Pharmacy Staffb 4.3 ± 1.4 (9) 7.3 ± 3.1 (10) 10.5 ± 6.2 (9) 14.5 ± 8.4 (10) 
aFTE = full-time equivalent 






















Percentage of respondent hospitals that provide selected clinical services, drug policy tools, and other non-
distributive services by hospital size group 
 




















Drug therapy monitoring 89 90 80 67 
Medication compliance and drug histories 56 40 44 40 
Patient education or counseling 22 60 44 10 
Pharmacokinetic consultations 22 50 22 20 
Nutritional support 0 20 0 0 
Antibiotic dosing and monitoring 33 80 33 50 
Culture & sensitivity follow-up 33 40 33 30 
Anticoagulation monitoring 56 100 56 80 
Pain management 33 56 0 30 
Medical rounds with physicians 33 20 44 20 
Medical emergency response 44 40 0 0 
Medication reconciliation 45 80 56 50 
Investigational drug services 0 10 0 0 
Renal dosing 44 50 44 60 
IV to PO conversions 0 0 0 30 
Drug Policy Tools 
Automatic generic substitution by pharmacy 64 80 60 90 
Automatic therapeutic interchange by pharmacy 46 40 10 60 
Using pharmacist interventions/recommendations 
to monitor prescriber compliance with policies 
73 100 80 100 
Pharmacist-provided education programs for 
providers about medication costs 
36 30 70 70 
Pharmacist prior approval of non-formulary 
medications 
64 60 60 60 
Development of clinical practice guidelines, 
which include medications 
27 60 40 60 
Pharmacist prescribing under protocol 9 10 0 10 
Retrospective medication use evaluation 46 90 80 80 
Pharmacist prior approval of restricted drugs 18 30 20 20 
Pharmacist-managed clinical support technology 
in hospital computer/order-entry system 
55 60 20 20 
Other 0 10 10 10 
Non-Distributive Services 
Drug research 0 30 20 40 
Medication error monitoring/reporting 73 90 90 100 
Drug information service 64 90 80 80 
Poison information service 9 30 30 20 
Adverse drug reaction monitoring/reporting  73 80 90 100 
In-service education  64 40 60 50 
Protocol development and/or management 46 60 70 70 
Clinical pharmacists in outpatient clinic(s) 9 10 0 0 
Other 0 10 30 10 




Calculated Workload and Productivity Ratios 
















Total pharmacy expenditures  










Total pharmacy expenditures 









Pharmaceutical expenditures  









Pharmaceutical expenditures  












































administered per month per 














administered per month per 













Orders per month per 100 























FTEs per 1000 doses 
dispensed/ 











FTEs per 1000 orders 































































































Productive hours paid per 









Clinical Interventions per 









Clinical Interventions per 
month per 100 occupied beds 
150±220(5) 83±125(10) 87±90(7) 30±19(10) 
Clinical Interventions per 









aSignificant difference (p<0.05) was found between mean value for the combined Very Small/Small group 
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Key Points  
• State resources for mental healthcare services are limited, requiring hospitals to 
operate as efficiently as possible.   
• Pharmacy administrators should use these new benchmarks for state psychiatric 
hospitals to identify opportunities for improving workforce efficiency, 
pharmaceutical care services, and financial performance, with the overall goal of 
improving value, with regards to pharmacy practice in their organizations. 
• Hospitals of larger size typically realize economies of scale as bed size increases, 
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 If Yes, what is the total number of hospitals in the system (including this one)? 
_____ 
 
3. Please provide the following information on the size of your hospital. Provide 























	 	 	 	
	
PHARMACY DEPARTMENT FINANCIAL AND STAFFING INFORMATION  
4. Which type of pharmacy facilities does the Department operate? Check ALL that 
apply and indicate the number of facilities/locations within the hospital if more than one exists. 
a Inpatient central pharmacy  number of facilities: _____ 
b Inpatient satellite pharmacies number of facilities: _____ 
c Outpatient clinic pharmacies number of facilities: _____ 
Study of Pharmacy Services in Small and Rural  
Hospitals in Illinois  
	167	
	
d Outpatient retail pharmacies number of facilities: _____ 
e Long-term care pharmacies, number of facilities: _____ 
f Other, describe: ___________ number of facilities: _____ 
 
5. Please provide the following information regarding hospital pharmacy 
expenditures. Provide information for the most recent 12 month period or for the most recent fiscal 
year. 
 





ii)	Total	pharmaceutical	expenditures*:	 	 	 	 	
	 $	________________	
*Include acquisition costs of pharmaceuticals (including blood-derived products and diagnostic agents, and 
IVs and others under the pharmacy budget). Combine expenditures of all pharmacy cost centers if more 
than one exists. 
If possible separate inpatient and outpatient pharmaceutical expenditures 
• Inpatient	pharmaceutical	expenditures:	 	 	 $	
________________	













• Inpatient	pharmaceutical	expenditures:	 	 	 $	
________________	






6. To whom does the Director of Pharmacy report (direct report) in the 






7. What non-pharmacy departments or service areas, if any, is the Director of 




8. What is the current staffing level (number of Full Time Equivalents, FTE’s) for 
each job class within the pharmacy department? Fill in the budgeted and actual number of 
FTE’s for each position as appropriate. One FTE is based on 40 hours per week of work time. Combine all 
















Director	 ______________	 ______________	 ______________	
Associate/Assistant	Director	 ______________	 ______________	 ______________	
Supervisor/Manager	 ______________	 ______________	 ______________	
Clinical	Coordinator/Manager	
______________	 ______________	 ______________	
Clinical	Pharmacist	 ______________	 ______________	 ______________	
Dispensing/Staff	Pharmacist	 ______________	 ______________	 ______________	
Integrated	Pharmacist		 ______________	 ______________	 ______________	
	(clinical	and	distributive)	 	 	 	
Informatics	Pharmacist	 ______________	 ______________	 ______________	
Medication	Use/Safety	Pharmacist	 ______________	 ______________	 ______________	
Other	Pharmacists	 ______________	 ______________	 ______________	
Pharmacy	Resident		 ______________	 ______________	 ______________	
Pharmacy	Technician	Buyer	 ______________	 ______________	 ______________	
Pharmacy	Technician	 ______________	 ______________	 ______________	
Secretary/Administrative	Assistant	______________	 ______________	 ______________	







10. In the past year, what is the most common reason given for why individuals left 













11. Compared to the previous year, has the rate of vacancies (any unfilled position/s 
in your department) for pharmacists increased, decreased, or stayed the same? Check 
ONE. 
1 Increased   2 Decreased  3 Stayed the same 8  No 
Vacancies or Not Applicable 
	
12. Compared to the previous year, has the rate of vacancies (any unfilled position/s 
in your department) for pharmacy technicians increased, decreased, or stayed the 
same? Check ONE. 
1 Increased   2 Decreased  3 Stayed the same 8  No 
Vacancies or Not Applicable 
	
13. What are the observable adverse effects if any of the current vacancies on the 


























1 Increased  2 Decreased  3 Stayed the same  8  No 
Vacancies/Not Applicable 
 
16. What actions have been taken in the past year to recruit or retain pharmacists? 










17. Are pharmacists that you hire typically new graduates or individuals who have 
been practicing for a while? Check ONE. 
1 New graduates 2 Practicing pharmacists 3 Both 
	
18. When you hire pharmacists, where do they usually come from (i.e., home town)? 
Check ALL that apply. 
1 Within the same county or bordering 
counties 
2 Other counties within  Illinois (not 
bordering)  
3 Bordering states (e.g., KY, MO, IN, 
IA, WI) 
4 Other states (not bordering) 
 
19. Do pharmacists that you hire usually come from (i.e., home town) rural settings 
or from larger metropolitan areas? Check ONE. 
1 From rural areas or small towns 2 From larger metropolitan areas and 
cities 
3 Both  
	
20. Do you feel that new graduates are adequately trained to fill your vacant 





21. Does the hospital pharmacy serve as a clerkship training site for one or more 











1 “Clinical specialist-centered model” – where there are separate distributive 











































Drug therapy monitoring 1 2 3 4 5 
Compliance and drug histories 1 2 3 4 5 
Patient education or counseling 1 2 3 4 5 
Pharmacokinetic consultations 1 2 3 4 5 
Nutritional support 1 2 3 4 5 
Antibiotic dosing and monitoring 1 2 3 4 5 
Anticoagulation monitoring 1 2 3 4 5 
Pain management 1 2 3 4 5 
Medical rounds with physicians 1 2 3 4 5 
Medical emergency response 1 2 3 4 5 
Medication reconciliation 1 2 3 4 5 
Investigational drug services 1 2 3 4 5 














1 No EMR 2 Partial EMR 3 Complete* EMR 
*A complete EMR contains all clinical documentation and orders, there are no paper-based charts. 
 
27. Are pharmacists able to access the electronic medical record? Check ONE. 
1	Yes	 0	No	 8	Not	applicable/No	EMR	
 
28. Do physicians use a computerized prescriber order-entry system (CPOE) system 
to order/prescribe medications for inpatients? Check ONE. 
1	Yes	 0	No	 	
 If Yes, what percentage of orders are entered into the system by prescribers? 
Check ONE. 









 If Yes, does the hospital utilize clinical decision support built into the CPOE 
system. Check ONE. 
	 1	Yes	 0	No	
 
29. If your hospital has outpatient clinics, do physicians there use an e-Prescribing 
system to write/communicate prescriptions for outpatients? Check ONE. 
1 Yes 0 No 8 Not applicable 
 If Yes, does the e-Prescribing system communicate orders to the outpatient 
pharmacy/ies? 
 1 Yes 0 No 8 Not applicable 
 
30. Which of the following best describes the pharmacy department computer 
system? Check ONE. 
0 No pharmacy computer system 
1 Pharmacy computer system is integrated in the hospital system or electronic medical 
record 
2 Stand alone pharmacy computer system interfaced to the hospital system 
3 Stand alone pharmacy computer system not interfaced to hospital system 




31. Is imaging technology used for inpatient order transcription? Check ONE. 




32. Is imaging technology used for outpatient or retail prescriptions? Check ONE. 
1 Yes 0 No 8 Not applicable 
 
33. Does the pharmacy utilize any off-site or remote medication order review or 
entry? Check ONE. 
0 None 






























































41. Does the pharmacy use machine-readable coding (bar coding) to verify doses 
before dispensing? Check ONE. 
1	Yes	 0	No	
 
42. In what type of facility does the pharmacy prepare sterile products? Check ONE. 











43. Does the sterile products preparation meet USP 797 standards? Check ONE. 
1	Yes	 0	No	 2	Don't	Know/Not	Sure	
	
44. What types of automation does the pharmacy use in sterile product preparation? 








45. What percent of sterile product doses are prepared by nurses on the nursing 
units (including after hours)? Check ONE. 
1 0-10% 2 11-25% 3 26-50% 4 >50%  
	




47. What other technologies, not questioned previously, are used in the inpatient 















48. Is the hospital pharmacy department involved in any use or application of 





49. Outpatient (retail) pharmacy services are provided by the hospital to which of 






50. What types of technologies are used in the hospital clinics or outpatient 























52. Which of the following technologies is used in the drug administration process? 







53. Who is primarily responsible for medication education and counseling of 








a Adverse drug reaction monitoring and reporting 
b Drug information to physicians and other health care providers 
c Medication use evaluations 
d Medication error monitoring and reporting 
e Poison information services 
f In-service education to physicians and other health care providers 







The University of Illinois at Chicago College of Pharmacy and the Illinois Council of 


























































































































December 6, 2016 
 
Dear Directors of Pharmacy, 
 
I am requesting your participation in an on-line survey, which is designed to define benchmark 
statistics for use in assessing workload, staffing, and productivity metrics in pharmacy 
departments of state psychiatric hospitals. As a fellow Director of Pharmacy for a state 
psychiatric hospital system, my goal is to help you (and me) by collecting and making this data 
available to pharmacy administrators in pharmacies just like ours.  We are surveying state 
psychiatric hospital pharmacies that are part of MMCAP; therefore, the data we collect will be 
directly applicable to your hospitals.   
 
The questionnaire is accessible at the following link: 
https://redcap.musc.edu./surveys/?s=H8EMWH839R or you may print the attached questionnaire, 
complete it, and scan/email it back to me at angela.smith@dhhs.nc.gov. 
 
As you know, standards for measuring such metrics in hospitals have never been well defined.  
Current pharmacy literature is from acute care hospitals, with psychiatric hospitals being 
excluded. This type of benchmark data would be invaluable as we strive to identify opportunities 
to improve workflow efficiency, patient care services, and financial performance. 
 
Please complete the brief questionnaire by January 4, including questions on occupied bed size, 
pharmacy expenditures, hours of operation, pharmacy services, methods used to measure 
workload and productivity, and staffing levels.  All of the questions require either checking a box 
or filling in a number and should take approximately 30 minutes to complete.  You are welcome 
to delegate the task of completing the questionnaire to another staff member, as you deem 
appropriate.  It may be helpful to print the attached questionnaire and complete it prior to 
submitting your answers through the online survey tool.   
 
Your participation will be strictly confidential.  Survey respondents’ facility names will be 
collected only for purposes of determining responders versus non-responders.  Facility names will 
not appear in the final report. 
 
Your participation is extremely important to the integrity of this study.  The more respondents we 
have, the more meaningful the data will be to us all.  Hospitals that participate in the survey will 
receive a copy of the final report.  This report should be useful to compare your own data to that 
of other respondents. 
 
If you have any questions regarding the survey, please do not hesitate to reach out to me.  If there 
is a more appropriate person to send this survey to, please provide that information to me, so 




Angela Smith, PharmD, MHA, BCPS, DHAc 
Director of Pharmacy 
North Carolina Department of Health and Human Services 
Division of State Operated Healthcare Facilities 
 
